Plasma lipoprotein(a) [Lp(a)], a low density lipoprotein particle with an attached apolipoprotein(a) [apo(a)], varies widely in concentration between individuals. These concentration differences are heritable and inversely related to the number of kringle 4 repeats in the apo(a) gene. To define the genetic determinants of plasma Lp(a) levels, plasma Lp(a) concentrations and apo(a) genotypes were examined in 48 nuclear Caucasian families. Apo(a) genotypes were determined using a newly developed pulsed-field gel electrophoresis method which distinguished 19 different genotypes at the apo(a) locus. The apo(a) gene itself was found to account for virtually all the genetic variability in plasma Lp(a) levels. This conclusion was reached by analyzing plasma Lp(a) levels in siblings who shared zero, one, or two apo(a) genes that were identical by descent (ibd). Siblings with both apo(a) alleles ibd (n = 72) have strikingly similar plasma Lp(a) levels (r = 0.95), whereas those who shared no apo(a) alleles (n = 52), had dissimilar concentrations (r = -0.23). The apo(a) gene was estimated to be responsible for 91% of the variance of plasma Lp(a) concentration. The number of kringle 4 repeats in the apo(a) gene accounted for 69% of the variation, and yet to be defined cis-acting sequences at the apo(a) locus accounted for the remaining 22% of the inter-individual variation in plasma Lp(a) levels. During the course of these studies we observed the de novo generation of a new apo(a) allele, an event that occurred once in 376 meioses.
E Boerwinkle, C C Leffert, J Lin, C Lackner, G Chiesa, H H Hobbs
Title and authors | Publication | Year |
---|---|---|
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease
Kalwick M, Roth M |
Nutrients | 2025 |
Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
Sheashaa H, Mousa H, Abbas MT, Farina JM, Awad K, Pereyra M, Scalia IG, Ali NB, Javadi N, Bismee NN, Esfahani SA, Ibrahim O, Abdelfattah F, Ibrahim R, Abdelnabi M, Ayoub C, Arsanjani R |
Biomolecules | 2025 |
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening
Clair V, Zirille FM, Gill E |
American Journal of Preventive Cardiology | 2025 |
The Association between Lipoprotein(a) and Coronary Artery Calcification in Elderly Patients with Diabetes: A Cross-Sectional Study
Qiu L, Qiao H |
Reviews in Cardiovascular Medicine | 2025 |
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Khan TG, Cunha JB, Raut C, Burroughs M, Vyas HS, Leix K, Goonewardena SN, Smrcka AV, Speliotes EK, Emmer BT |
Atherosclerosis | 2025 |
Lipoprotein(a) and Risk of Incident Atherosclerotic Cardiovascular Disease: Impact of High-Sensitivity C-Reactive Protein and Risk Variability Among Human Clinical Subgroups
Hoogeveen RC, Diffenderfer MR, Lim E, Liu CT, Ikezaki H, Guan W, Tsai MY, Ballantyne CM |
Nutrients | 2025 |
Patient Experience of Heart Disease with Elevated Lipoprotein(a): Views from a Patient, His Physician, and a Patient Association.
Favereaux S, Durlach V, Vercoustre B |
Cardiology and therapy | 2025 |
2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings.
Sosnowska B, Toth PP, Razavi AC, Remaley AT, Blumenthal RS, Banach M |
Archives of medical science : AMS | 2025 |
Lipoprotein(a): from Causality to Treatment.
Kronenberg F |
Current Atherosclerosis Reports | 2024 |
Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.
Sosnowska B, Stepinska J, Mitkowski P, Bielecka-Dabrowa A, Bobrowska B, Budzianowski J, Burchardt P, Chlebus K, Dobrowolski P, Gasior M, Jankowski P, Kubica J, Mickiewicz A, Mysliwiec M, Osadnik T, Prejbisz A, Rajtar-Salwa R, Wita K, Witkowski A, Gil R, Banach M |
Archives of Medical Science : AMS | 2024 |
Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization
Barbieri G, Cassioli G, Kura A, Orsi R, Magi A, Berteotti M, Scaturro GM, Lotti E, Gori AM, Marcucci R, Giusti B, Sticchi E |
Journal of Clinical Laboratory Analysis | 2024 |
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial.
Nissen SE, Wolski K, Watts GF, Koren MJ, Fok H, Nicholls SJ, Rider DA, Cho L, Romano S, Melgaard C, Rambaran C |
Journal of the American Medical Association | 2024 |
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Khan TG, Cunha JB, Raut C, Burroughs M, Goonewardena SN, Smrcka AV, Speliotes EK, Emmer BT |
2024 | |
Measuring Lp(a) particles with a novel isoform-insensitive immunoassay demonstrates potent efficacy of muvalaplin
Craig Swearingen, John Sloan, Grace M. Rhodes, Robert W. Siegel, Nico Bivi, Yuewei Qian, Robert Konrad, Michael Boffa, Marlys Koschinsky, John Krege, Giacomo Ruotolo, Stephen Nicholls, Laura Michael, Yi Wen |
Journal of lipid research | 2024 |
Highlighting the South Asian Heart Failure Epidemic.
Srinivasan N, Gullapalli N, Shah KS |
Cardiac Failure Review | 2024 |
Lipoprotein(a) and diet: consuming sugar-sweetened beverages lowers lipoprotein(a) levels in obese and overweight adults
Law HG, Stanhope KL, Zhang W, Myagmarsuren M, Jamshed ZM, Khan MA, Bang H, Havel PJ, Berglund L, Enkhmaa B |
Journal of Lipid Research | 2024 |
Therapeutic Gene Editing in Dyslipidemias
Tamehri Zadeh SS, Shapiro MD |
Reviews in Cardiovascular Medicine | 2024 |
Lipoprotein (a) and the Occurrence of Lipid Disorders and Other Cardiovascular Risk Factors in Patients without Diagnosed Cardiovascular Disease
Ratajczak J, Kubica A, Pietrzykowski Ł, Michalski P, Kosobucka-Ozdoba A, Buczkowski K, Krintus M, Jankowski P, Kubica J |
Journal of Clinical Medicine | 2024 |
Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk.
Mukherjee D, Nissen SE |
Current vascular pharmacology | 2024 |
Nanopore sequencing with unique molecular identifiers enables accurate mutation analysis and haplotyping in the complex lipoprotein(a) KIV-2 VNTR.
Amstler S, Streiter G, Pfurtscheller C, Forer L, Di Maio S, Weissensteiner H, Paulweber B, Schönherr S, Kronenberg F, Coassin S |
Genome medicine | 2024 |
Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder.
Annink ME, Janssen ES, Reeskamp LF |
Current opinion in lipidology | 2024 |
A scalable adaptive quadratic kernel method for interpretable epistasis analysis in complex traits.
Fu B, Anand P, Anand A, Mefford J, Sankararaman S |
Genome research | 2024 |
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Nissen SE, Wang Q, Nicholls SJ, Navar AM, Ray KK, Schwartz GG, Szarek M, Stroes ES, Troquay R, Dorresteijn JA, Fok H, Rider DA, Romano S, Wolski K, Rambaran C |
JAMA | 2024 |
Lipoprotein (a): Underrecognized Risk with a Promising Future
Manzato M, Wright RS, Jaffe AS, Vasile VC |
Reviews in Cardiovascular Medicine | 2024 |
Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition
Andersen CJ, Fernandez ML |
Nutrients | 2024 |
Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History
Tada H, Kojima N, Yamagami K, Takeji Y, Sakata K, Usui S, Kawashiri MA, Takamura M |
Journal of Lipid and Atherosclerosis | 2024 |
Genome Editing in Dyslipidemia and Atherosclerosis.
Chen Z, Lehertshuber C, Schunkert H |
Advances in experimental medicine and biology | 2023 |
Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort.
Matveyenko A, Matienzo N, Ginsberg H, Nandakumar R, Seid H, Ramakrishnan R, Holleran S, Thomas T, Reyes-Soffer G |
Journal of lipid research | 2023 |
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors
Levstek T, Karun T, Rehberger Likozar A, Šebeštjen M, Trebušak Podkrajšek K |
Genes & development | 2023 |
Genetics of aortic valve disease.
Ackah RL, Yasuhara J, Garg V |
Current Opinion in Cardiology | 2023 |
Relationship between lipoprotein(a) levels, cardiovascular outcomes and death in patients with chronic kidney disease: a systematic review of prospective studies.
Barbagelata L, Masson W, Corral P, Lavalle-Cobo A, Nogueira JP, Rosa Diez G |
Journal of Nephrology | 2023 |
Lipoprotein (a), Inflammation, and Atherosclerosis.
Di Fusco SA, Maggioni AP, Scicchitano P, Zuin M, D'Elia E, Colivicchi F |
Journal of Clinical Medicine | 2023 |
Lipoprotein (a): Does It Play a Role in Pediatric Ischemic Stroke and Thrombosis?
Torres M, Schenk A |
Current Atherosclerosis Reports | 2023 |
Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors.
Likozar AR, Šebeštjen M |
Cardiovascular ultrasound | 2023 |
Lipoprotein(a) and diet-a challenge for a role of saturated fat in cardiovascular disease risk reduction?
Law HG, Meyers FJ, Berglund L, Enkhmaa B |
The American journal of clinical nutrition | 2023 |
Reducing saturated fat intake lowers LDL-C but increases Lp(a) levels in African Americans: the GET-READI feeding trial.
Law HG, Khan MA, Zhang W, Bang H, Rood J, Most M, Lefevre M, Berglund L, Enkhmaa B |
Journal of lipid research | 2023 |
Association of free-living diet composition with plasma lipoprotein(a) levels in healthy adults.
Matveyenko A, Seid H, Kim K, Ramakrishnan R, Thomas T, Matienzo N, Reyes-Soffer G |
Lipids in Health and Disease | 2023 |
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?
Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P, Bulfone L, Vacca A, Bertin N, Vivarelli C, Comand J, Catena C, Sechi LA |
International journal of molecular sciences | 2023 |
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.
Vinci P, Di Girolamo FG, Panizon E, Tosoni LM, Cerrato C, Pellicori F, Altamura N, Pirulli A, Zaccari M, Biasinutto C, Roni C, Fiotti N, Schincariol P, Mangogna A, Biolo G |
International journal of environmental research and public health | 2023 |
Concordance of a High Lipoprotein(a) Concentration Among Relatives.
Reeskamp LF, Tromp TR, Patel AP, Ibrahim S, Trinder M, Haidermota S, Hovingh GK, Stroes ESG, Natarajan P, Khera AV |
JAMA Cardiology | 2023 |
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial.
Nissen SE, Linnebjerg H, Shen X, Wolski K, Ma X, Lim S, Michael LF, Ruotolo G, Gribble G, Navar AM, Nicholls SJ |
Journal of the American Medical Association | 2023 |
Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
Gilliland TC, Liu Y, Mohebi R, Miksenas H, Haidermota S, Wong M, Hu X, Cristino JR, Browne A, Plutzky J, Tsimikas S, Januzzi JL Jr, Natarajan P |
Journal of the American College of Cardiology | 2023 |
Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.
Coassin S, Chemello K, Khantalin I, Forer L, Döttelmayer P, Schönherr S, Grüneis R, Chong-Hong-Fong C, Nativel B, Ramin-Mangata S, Gallo A, Roche M, Muelegger B, Gieger C, Peters A, Zschocke J, Marimoutou C, Meilhac O, Lamina C, Kronenberg F, Blanchard V, Lambert G |
Circulation. Genomic and precision medicine | 2022 |
Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
Clark JR, Gemin M, Youssef A, Marcovina SM, Prat A, Seidah NG, Hegele RA, Boffa MB, Koschinsky ML |
Journal of lipid research | 2022 |
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics.
Swerdlow DI, Rider DA, Yavari A, Wikström Lindholm M, Campion GV, Nissen SE |
Cardiovascular Research | 2022 |
Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk.
Trinder M, Paruchuri K, Haidermota S, Bernardo R, Zekavat SM, Gilliland T, Januzzi J Jr, Natarajan P |
Journal of the American College of Cardiology | 2022 |
Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
Alonso R, Argüeso R, Álvarez-Baños P, Muñiz-Grijalvo O, Diaz-Diaz JL, Mata P |
Current Atherosclerosis Reports | 2022 |
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
Coassin S, Kronenberg F |
Atherosclerosis | 2022 |
A method for lipoprotein (a) Isolation from a small volume of plasma with applications for clinical research.
Mueller PA, Yerkes E, Bergstrom P, Rosario S, Hay J, Pamir N |
Scientific Reports | 2022 |
Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome.
Kato A, Kinoshita D, Nagata T, Asakura K, Katamine M, Katsura A, Hashimoto T, Minami Y, Ako J |
2022 | |
A Modern Approach to Dyslipidemia.
Berberich AJ, Hegele RA |
Endocrine reviews | 2022 |
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
Nissen SE, Wolski K, Balog C, Swerdlow DI, Scrimgeour AC, Rambaran C, Wilson RJ, Boyce M, Ray KK, Cho L, Watts GF, Koren M, Turner T, Stroes ES, Melgaard C, Campion GV |
Journal of the American Medical Association | 2022 |
Glucose metabolism status modifies the relationship between lipoprotein(a) and carotid plaques in individuals with fatty liver disease.
Wang J, Sun H, Wang Y, An Y, Liu J, Wang G |
Frontiers in Endocrinology | 2022 |
Genetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and “Missing” Heritability
JM Martín-Campos |
Biomedicines | 2021 |
Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation
G Reyes-Soffer, M Westerterp |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2021 |
Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer
SP Wyness, JR Genzen |
Practical Laboratory Medicine | 2021 |
Protein-coding repeat polymorphisms strongly shape diverse human phenotypes
RE Mukamel, RE Handsaker, MA Sherman, AR Barton, Y Zheng, SA McCarroll, PR Loh |
Science | 2021 |
Lipoprotein (a): When to Measure and How to Treat?
D Rhainds, MR Brodeur, JC Tardif |
Current Atherosclerosis Reports | 2021 |
Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease
M Trinder, M Uddin, P Finneran, KG Aragam, P Natarajan |
JAMA Cardiology | 2021 |
Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen
E Karwatowska-Prokopczuk, N Clouet-Foraison, S Xia, NJ Viney, JL Witztum, SM Marcovina, S Tsimikas |
Atherosclerosis | 2021 |
A review on clotting disorders and retinal hemorrhages: Can they mimic abuse?
A Thau, B Saffren, JD Anderst, SL Carpenter, AV Levin |
Child Abuse & Neglect | 2021 |
Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank
E Widen, TG Raben, L Lello, SD Hsu |
Genes & development | 2021 |
Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health?
D Yannas, F Frizza, L Vignozzi, G Corona, M Maggi, G Rastrelli |
Journal of Clinical Medicine | 2021 |
The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk
G Reyes-Soffer |
Current Opinion in Lipidology | 2021 |
Lipid Optimization in Lower Extremity Peripheral Arterial Disease
PP Sucharitkul, KL Jones, DJ Scott, MA Bailey |
Annals of Vascular Surgery | 2021 |
Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis
P Kumar, P Swarnkar, S Misra, M Nath |
Scientific Reports | 2021 |
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study
M Arnold, J Schweizer, CT Nakas, V Schütz, LP Westphal, C Inauen, T Pokorny, A Luft, A Leichtle, M Arnold, A Bicvic, U Fischer, GM Marchis, LH Bonati, MD Müller, T Kahles, K Nedeltchev, CW Cereda, G Kägi, A Bustamante, J Montaner, G Ntaios, C Foerch, K Spanaus, A von Eckardstein, M Katan |
European Heart Journal | 2021 |
Cardiovascular Disease in Racial and Ethnic Minority Populations
KC Ferdinand, HA Taylor, CJ Rodriguez |
2021 | |
Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation
V Marco-Benedí, A Cenarro, M Laclaustra, A Larrea-Sebal, E Jarauta, I Lamiquiz-Moneo, P Calmarza, AM Bea, N Plana, X Pintó, C Martín, F Civeira |
Atherosclerosis | 2021 |
Blood biomarker levels by total sleep duration: cross-sectional analyses in UK Biobank
TY Wong, RC Travis, TY Tong |
Sleep Medicine | 2021 |
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
DI Swerdlow, DA Rider, A Yavari, MW Lindholm, GV Campion, SE Nissen |
Cardiovascular Research | 2021 |
Lipoprotein(a) Levels at Birth and in Early Childhood: The COMPARE Study
N Strandkjær, MK Hansen, ST Nielsen, R Frikke-Schmidt, A Tybjærg-Hansen, BG Nordestgaard, A Tabor, H Bundgaard, K Iversen, PR Kamstrup |
The Journal of clinical endocrinology and metabolism | 2021 |
Proteomic studies on apoB‐containing lipoprotein in cardiovascular research: A comprehensive review
E Gianazza, B Zoanni, A Mallia, M Brioschi, GI Colombo, C Banfi |
Mass Spectrometry Reviews | 2021 |
Changes of lipoprotein(a) levels with endogenous steroid hormones
E Tessitore, K Dobretz, NA Dhayat, I Kern, B Ponte, M Pruijm, D Ackermann, S Estoppey, M Burnier, PY Martin, B Vogt, N Vuilleumier, M Bochud, F Mach, G Ehret |
European Journal of Clinical Investigation | 2021 |
A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter
S Coassin, N Hermann-Kleiter, M Haun, S Wahl, R Wilson, B Paulweber, S Kunze, T Meitinger, K Strauch, A Peters, M Waldenberger, F Kronenberg, C Lamina, DC Crawford |
PloS one | 2020 |
Acute and Chronic Impact of Biliopancreatic Diversion with Duodenal Switch Surgery on Plasma Lipoprotein(a) Levels in Patients with Severe Obesity
AA Després, ME Piché, A Auclair, L Biertho, S Marceau, FS Hould, S Biron, S Lebel, O Lescelleur, F Julien, J Martin, A Tchernof, P Mathieu, P Poirier, BJ Arsenault |
Obesity Surgery | 2020 |
DNA methylation profiling identifies a high effect genetic variant for lipoprotein(a) levels
GT Jones, J Marsman, B Bhat, VL Phillips, A Chatterjee, EJ Rodger, MJ Williams, AM van Rij, SP McCormick |
Epigenetics : official journal of the DNA Methylation Society | 2020 |
Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia
M Trinder, ML DeCastro, H Azizi, L Cermakova, LM Jackson, J Frohlich, GB Mancini, GA Francis, LR Brunham |
Journal of the American College of Cardiology | 2020 |
Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
AR Likozar, M Zavrtanik, M Šebeštjen |
Annals of Medicine | 2020 |
Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals
SD Maio, R Grüneis, G Streiter, C Lamina, M Maglione, S Schoenherr, D Öfner, B Thorand, A Peters, KU Eckardt, A Köttgen, F Kronenberg, S Coassin |
Genome Medicine | 2020 |
PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability
B Enkhmaa, K Kim, W Zhang, N Prakash, K Truax, E Anuurad, L Berglund |
Journal of the Endocrine Society | 2020 |
The Prevalence of Elevated Lipoprotein(a) in Patients Presenting With Coronary Artery Disease
HP Oo, J Giovannucci, RC OBrien, DL Hare |
Heart, lung & circulation | 2020 |
Plasma lipoprotein(a) concentration as an independent predictor of hemodynamic progression of aortic valve stenosis
VD Tomova, ML Alexandrova, MA Atanasova, ML Tzekova, TR Rashev, S Ahmad |
Molecular and Cellular Biochemistry | 2020 |
Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease
I Jung, H Kwon, SE Park, CY Park, WY Lee, KW Oh, SW Park, EJ Rhee |
Atherosclerosis | 2020 |
Papel de los lípidos en la ateroesclerosis
F Civeira, V Marco-Benedí, A Cenarro |
Revista Española de Cardiología Suplementos | 2020 |
The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease in Healthy Individuals: A Review of Human Intervention Trials
E Froyen, B Burns-Whitmore |
Nutrients | 2020 |
The role of Lipoprotein(a) in cardiovascular disease: Current concepts and future perspectives
MA Vavuranakis, SR Jones, R Cardoso, G Gerstenblith, TM Leucker |
HELL J CARDIOL | 2020 |
Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
MA Kachkovsky, IP Vvedenskaya, VY Vvedensky, AA Supilnikov, JV Ponomareva, MN Milyakova |
2020 | |
Serum Lipoprotein (a) on Postoperative Day 3: A Strong Predictor of Portal and/or Splenic Vein Thrombosis in Cirrhotic Patients With Splenectomy
Z Shi, M Zhang, X Dong, J Xu |
Clinical and Applied Thrombosis/Hemostasis | 2020 |
Prevalence and status of Lipoprotein (a) among Lebanese school children
MH Gannagé-Yared, C Lahoud, N Younes, R Chedid, G Sleilaty |
Scientific Reports | 2020 |
Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study
F Moosaie, RM Davatgari, FD Firouzabadi, S Esteghamati, N Deravi, A Meysamie, P Khaloo, M Nakhjavani, A Esteghamati |
Canadian Journal of Diabetes | 2020 |
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
CA German, MD Shapiro |
European Cardiology Review | 2020 |
Type 1 diabetes mellitus, familial hypercholesterolemia, and elevated lipoprotein (a)
L Hamilton, C McNeal, D Wilson |
Proceedings (Baylor University. Medical Center) | 2020 |
Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels
M Hoekstra, HY Chen, J Rong, L Dufresne, J Yao, X Guo, MY Tsai, S Tsimikas, WS Post, RS Vasan, JI Rotter, MG Larson, G Thanassoulis, JC Engert |
Arteriosclerosis, thrombosis, and vascular biology | 2020 |
Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT)
LT Appiah, FS Sarfo, SB Nguah, MD Huffman, JK Stiles, MJ Feinstein |
Global Heart | 2020 |
Lipoprotein(a) and its Clinical Importance
FZ avval, malihe Moammeri Salahshooh, |
2020 | |
Plasma lipoprotein(a) concentration as an independent predictor of hemodynamic progression of aortic valve stenosis.
Tomova VD, Alexandrova ML, Atanasova MA, Tzekova ML, Rashev TR, Ahmad S |
Molecular and Cellular Biochemistry | 2020 |
Nucleic Acid Therapies for Ischemic Stroke
N Henninger, Y Mayasi |
Neurotherapeutics | 2019 |
The Role of (Modified) Lipoproteins in Vascular Function: A Duet Between Monocytes and the Endothelium
JG Schnitzler, GM Dallinga-Thie, J Kroon |
Current medicinal chemistry | 2019 |
The Future of Lipid-lowering Therapy
Zwol, Rimbert, Kuivenhoven |
Journal of Clinical Medicine | 2019 |
Risk factors for valvular calcification:
HY Chen, JC Engert, G Thanassoulis |
Current opinion in endocrinology, diabetes, and obesity | 2019 |
Dietary natural products as emerging lipoprotein(a)-lowering agents: MOMTAZI-BOROJENI et al
AA Momtazi-Borojeni, N Katsiki, M Pirro, M Banach, KA Rasadi, A Sahebkar |
Journal of Cellular Physiology | 2019 |
Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
H Tada, M Takamura, M Kawashiri |
Journal of Atherosclerosis and Thrombosis | 2019 |
Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels
G Cai, Z Huang, B Zhang, L Yu, L Li |
Bioscience Reports | 2019 |
Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families
B Enkhmaa, E Anuurad, W Zhang, K Kim, L Berglund |
Journal of lipid research | 2019 |
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults
MT Mefford, SM Marcovina, V Bittner, M Cushman, TM Brown, ME Farkouh, S Tsimikas, KL Monda, JA López, P Muntner, RS Rosenson |
Journal of lipid research | 2019 |
Laboratory medicine: health evaluation in elite athletes
B Lombardo, V Izzo, D Terracciano, A Ranieri, C Mazzaccara, F Fimiani, A Cesaro, L Gentile, E Leggiero, R Pero, B Izzo, AC DAlicandro, D Ercolini, G DAlicandro, G Frisso, L Pastore, P Calabrò, O Scudiero |
Clinical Chemistry and Laboratory Medicine | 2019 |
Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options
AN Berman, R Blankstein |
Current Cardiology Reports | 2019 |
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives
MF Wu, KZ Xu, YG Guo, J Yu, Y Wu, LM Lin |
Cardiovascular Drugs and Therapy | 2019 |
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
DF Gudbjartsson, G Thorgeirsson, P Sulem, A Helgadottir, A Gylfason, J Saemundsdottir, E Bjornsson, GL Norddahl, A Jonasdottir, A Jonasdottir, HP Eggertsson, S Gretarsdottir, G Thorleifsson, OS Indridason, R Palsson, F Jonasson, I Jonsdottir, GI Eyjolfsson, O Sigurdardottir, I Olafsson, R Danielsen, SE Matthiasson, S Kristmundsdottir, BV Halldorsson, AB Hreidarsson, EM Valdimarsson, T Gudnason, R Benediktsson, V Steinthorsdottir, U Thorsteinsdottir, H Holm, K Stefansson |
Journal of the American College of Cardiology | 2019 |
Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype
R Yahya, K Berk, A Verhoeven, S Bos, L van der Zee, J Touw, G Erhart, F Kronenberg, R Timman, E Sijbrands, JR van Lennep, M Mulder |
Atherosclerosis | 2019 |
LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia
M Paquette, S Bernard, G Thanassoulis, A Baass |
Journal of Clinical Lipidology | 2019 |
Nonsynonymous SNPs in LPA homologous to plasminogen deficiency mutants represent novel null apo(a) alleles
BM Morgan, AN Brown, N Deo, TW Harrop, G Taiaroa, PD Mace, SM Wilbanks, TR Merriman, MJ Williams, SP McCormick |
Journal of lipid research | 2019 |
Comparison of Coronary Atherosclerotic Plaque Burden and Composition as Assessed on Coronary Computed Tomography Angiography in East Asian and European-Origin Caucasians
AR Ihdayhid, M Goeller, D Dey, N Nerlekar, G Yap, U Thakur, D Adams, J Cameron, S Seneviratne, S Achenbach, B Ko |
The American Journal of Cardiology | 2019 |
Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks
RS Najjar, CE Moore, BD Montgomery |
Clinical Cardiology | 2018 |
Establishing age and sex dependent upper reference limits for the plasma lipoprotein (a) in a Chinese health check-up population and according to its relative risk of primary myocardial infarction
FM Cui, F Fang, YM He, DP Cai, J He, XJ Yang |
Clinica chimica acta; international journal of clinical chemistry | 2018 |
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis
S Burgess, BA Ference, JR Staley, DF Freitag, AM Mason, SF Nielsen, P Willeit, R Young, P Surendran, S Karthikeyan, TR Bolton, JE Peters, PR Kamstrup, A Tybjærg-Hansen, M Benn, A Langsted, P Schnohr, S Vedel-Krogh, CJ Kobylecki, I Ford, C Packard, S Trompet, JW Jukema, N Sattar, ED Angelantonio, D Saleheen, JM Howson, BG Nordestgaard, AS Butterworth, J Danesh |
JAMA Cardiology | 2018 |
Apolipoprotein(a) is the Product of a Pseudogene: Implications for the Pathophysiology of Lipoprotein(a)
GD Sloop, G Pop, JJ Weidman, JA Cyr |
Cureus | 2018 |
Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records
HY Chen, L Dufresne, H Burr, A Ambikkumar, N Yasui, K Luk, DK Ranatunga, RA Whitmer, M Lathrop, JC Engert, G Thanassoulis |
JAMA Cardiology | 2018 |
Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women’s Interagency HIV Study
B Enkhmaa, E Anuurad, W Zhang, CS Li, R Kaplan, J Lazar, D Merenstein, R Karim, B Aouizerat, M Cohen, K Butler, S Pahwa, I Ofotokun, AA Adimora, E Golub, L Berglund |
Journal of lipid research | 2018 |
Contextualizing selection bias in Mendelian randomization: how bad is it likely to be?
A Gkatzionis, S Burgess |
International Journal of Epidemiology | 2018 |
In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members
AW Zawacki, A Dodge, KM Woo, JC Ralphe, AL Peterson |
Journal of Clinical Lipidology | 2018 |
Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment Options
BA Ference |
Clinical Pharmacology & Therapeutics | 2018 |
A comprehensive map of single-base polymorphisms in the hypervariable LPA kringle IV type 2 copy number variation region
S Coassin, S Schönherr, H Weissensteiner, G Erhart, L Forer, JL Losso, C Lamina, M Haun, G Utermann, B Paulweber, G Specht, F Kronenberg |
Journal of lipid research | 2018 |
Heart Genomics
H Jiang, M Liu |
2018 | |
Cardiovascular Disease: Diet, Nutrition and Emerging Risk Factors
S Stanner, S Coe, KN Frayn |
2018 | |
Lipids in Children and Links to Adult Vascular Disease
John C Coakley |
The Clinical Biochemist Reviews | 2018 |
The metabolism of lipoprotein (a): an ever-evolving story
G Reyes-Soffer, HN Ginsberg, R Ramakrishnan |
Journal of lipid research | 2017 |
Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes
KA Berk, R Yahya, AJ Verhoeven, J Touw, FP Leijten, EF van Rossum, VL Wester, MA Lips, H Pijl, R Timman, G Erhart, F Kronenberg, JE van Lennep, EJ Sijbrands, MT Mulder |
Diabetologia | 2017 |
Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
R Romagnuolo, CA Scipione, SM Marcovina, M Gemin, NG Seidah, MB Boffa, ML Koschinsky, MC Vinci |
PloS one | 2017 |
Male Hypogonadism
SJ Winters, IT Huhtaniemi |
Male Hypogonadism | 2017 |
Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease
JG Smith, RE Gerszten |
Circulation | 2017 |
Pathobiology of Lp(a) in calcific aortic valve disease
P Mathieu, BJ Arsenault, MC Boulanger, Y Bossé, ML Koschinsky |
Expert Review of Cardiovascular Therapy | 2017 |
Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk
BJ Arsenault, F Petrides, F Tabet, W Bao, GK Hovingh, SM Boekholdt, S Ramin-Mangata, O Meilhac, D DeMicco, KA Rye, DD Waters, JJ Kastelein, P Barter, G Lambert |
Journal of Clinical Lipidology | 2017 |
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
S Mack, S Coassin, R Rueedi, NA Yousri, I Seppälä, C Gieger, S Schönherr, L Forer, G Erhart, P Marques-Vidal, JS Ried, G Waeber, S Bergmann, D Dähnhardt, A Stöckl, OT Raitakari, M Kähönen, A Peters, T Meitinger, K Strauch, L Kedenko, B Paulweber, T Lehtimäki, SC Hunt, P Vollenweider, C Lamina, F Kronenberg |
Journal of lipid research | 2017 |
Lipoprotein(a) and HIVHighlights: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima–Media Thickness in HIV-Infected Young Women in the Women’s Interagency HIV Study
B Enkhmaa, E Anuurad, W Zhang, CS Li, R Kaplan, J Lazar, D Merenstein, R Karim, B Aouizerat, M Cohen, K Butler, S Pahwa, I Ofotokun, AA Adimora, E Golub, L Berglund |
Arteriosclerosis, thrombosis, and vascular biology | 2017 |
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study
N Perrot, R Verbeek, M Sandhu, SM Boekholdt, GK Hovingh, NJ Wareham, KT Khaw, BJ Arsenault |
Atherosclerosis | 2017 |
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
S Zewinger, ME Kleber, V Tragante, RO McCubrey, AF Schmidt, K Direk, U Laufs, C Werner, W Koenig, D Rothenbacher, U Mons, LP Breitling, H Brenner, RT Jennings, I Petrakis, S Triem, M Klug, A Filips, S Blankenberg, C Waldeyer, C Sinning, RB Schnabel, KJ Lackner, E Vlachopoulou, O Nygård, GF Svingen, ER Pedersen, GS Tell, J Sinisalo, MS Nieminen, R Laaksonen, S Trompet, RA Smit, N Sattar, JW Jukema, HV Groesdonk, G Delgado, T Stojakovic, AP Pilbrow, VA Cameron, AM Richards, RN Doughty, Y Gong, R Cooper-DeHoff, J Johnson, M Scholz, F Beutner, J Thiery, JG Smith, RO Vilmundarson, R McPherson, AF Stewart, S Cresci, PA Lenzini, JA Spertus, O Olivieri, D Girelli, NI Martinelli, A Leiherer, CH Saely, H Drexel, A Mündlein, PS Braund, CP Nelson, NJ Samani, D Kofink, IE Hoefer, G Pasterkamp, AA Quyyumi, YA Ko, JA Hartiala, H Allayee, WH Tang, SL Hazen, N Eriksson, C Held, E Hagström, L Wallentin, A Åkerblom, A Siegbahn, I Karp, C Labos, L Pilote, JC Engert, JM Brophy, G Thanassoulis, P Bogaty, W Szczeklik, M Kaczor, M Sanak, SS Virani, CM Ballantyne, VV Lee, E Boerwinkle, MV Holmes, BD Horne, A Hingorani, FW Asselbergs, RS Patel, BK Krämer, H Scharnagl, D Fliser, W März, T Speer |
The Lancet Diabetes & Endocrinology | 2017 |
Lp(a) in Childhood
CJ Prendergast, JC Kelley, EF Linton, MR Linton |
Current Cardiovascular Risk Reports | 2017 |
Lipoprotein(a): new insights from modern genomics
M Afshar, G Thanassoulis |
Current Opinion in Lipidology | 2017 |
Inverse Association of Lipoprotein (a) With Markers of Insulin Resistance in Dyslipidemic Subjects
H Vaverková, D Karásek, M Halenka, L Cibíčková, V Kubíčková |
Physiological research / Academia Scientiarum Bohemoslovaca | 2017 |
Genetic markers: Potential candidates for cardiovascular disease
RA Rather, V Dhawan |
International Journal of Cardiology | 2016 |
Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions
O Bilen, A Kamal, SS Virani |
World journal of cardiology | 2016 |
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease
EA Stein, F Raal |
Cardiovascular Drugs and Therapy | 2016 |
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
F Kronenberg |
Cardiovascular Drugs and Therapy | 2016 |
Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis
C Yeang, B Cotter, S Tsimikas |
Cardiovascular Drugs and Therapy | 2016 |
Plasma lipoprotein(a) predicts major cardiovascular events in patients with chronic kidney disease who undergo percutaneous coronary intervention
H Konishi, K Miyauchi, S Tsuboi, M Ogita, R Naito, T Dohi, T Kasai, H Tamura, S Okazaki, K Isoda, H Daida |
International Journal of Cardiology | 2016 |
Structure, function, and genetics of lipoprotein (a)
K Schmidt, A Noureen, F Kronenberg, G Utermann |
Journal of lipid research | 2016 |
Searching for a common mechanism for placenta-mediated pregnancy complications and cardiovascular disease: role of lipoprotein(a)
I Romagnuolo, E Sticchi, M Attanasio, E Grifoni, G Cioni, AP Cellai, R Abbate, C Fatini |
Fertility and Sterility | 2016 |
A Case-Control Study of the Relationship Between SLC22A3-LPAL2-LPA Gene Cluster Polymorphism and Coronary Artery Disease in the Han Chinese Population
ZK Song, HY Cao, HD Wu, LT Zhou, L Qin |
Iranian Red Crescent Medical Journal | 2016 |
Lipoprotein(a) and Increased Cardiovascular Risk in Women: Lp(a) and increased CVD risk in women
BT Costello, ER Silverman, R Doukky, LT Braun, NT Aggarwal, Y Deng, Y Li, G Lundberg, KA Williams, AS Volgman |
Clinical Cardiology | 2016 |
Recurrent Embolic Strokes of Undetermined Source in a Patient with Extreme Lipoprotein(a) Levels
Z Bulwa, A Kim, K Singh, A Kantorovich, F Suhail |
Frontiers in neurology | 2016 |
Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study
F Fogacci, AF Cicero, S D'Addato, L D'Agostini, M Rosticci, M Giovannini, E Bertagnin, C Borghi |
European Journal of Internal Medicine | 2016 |
Lipoprotein(a) and risk of sudden cardiac death in middle-aged Finnish men: A new prospective cohort study
SK Kunutsor, H Khan, K Nyyssönen, JA Laukkanen |
International Journal of Cardiology | 2016 |
Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
M Banach |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2016 |
Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)
M Afshar, L Pilote, L Dufresne, JC Engert, G Thanassoulis |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2016 |
Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black IndividualsSignificance: The Multi-Ethnic Study of Atherosclerosis
J Cao, BT Steffen, M Budoff, WS Post, G Thanassoulis, B Kestenbaum, JP McConnell, R Warnick, W Guan, MY Tsai |
Arteriosclerosis, thrombosis, and vascular biology | 2016 |
Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study
R Verbeek, SM Boekholdt, RM Stoekenbroek, GK Hovingh, JL Witztum, NJ Wareham, MS Sandhu, KT Khaw, S Tsimikas |
Journal of lipid research | 2016 |
Ischemic stroke in a young adult with extremely elevated lipoprotein(a): A case report and review of literature
D Lakshminarayan, TK Elajami, S Devabhaktuni, FK Welty |
Journal of Clinical Lipidology | 2016 |
Impact of Lipoprotein(a) on Long-term Outcomes in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
H Konishi, K Miyauchi, J Shitara, H Endo, H Wada, S Doi, R Naito, S Tsuboi, M Ogita, T Dohi, T Kasai, S Okazaki, K Isoda, S Suwa, H Daida |
The American Journal of Cardiology | 2016 |
The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis
J Hurtubise, K McLellan, K Durr, O Onasanya, D Nwabuko, JF Ndisang |
Current Atherosclerosis Reports | 2016 |
Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease
MB Boffa |
Current Atherosclerosis Reports | 2016 |
Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke
XW Hong, DM Wu, J Lu, YL Zheng, WJ Tu, J Yan |
Molecular Neurobiology | 2016 |
STUDY OF LIPOPROTEIN (A) LEVELS AS A RISK FACTOR IN PATIENTS WITH ESSENTIAL HYPERTENSION IN A TERTIARY CARE HOSPITAL
AS Menon, V V.S, N V, L Madhavan |
2016 | |
Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor
R Romagnuolo, CA Scipione, MB Boffa, SM Marcovina, NG Seidah, ML Koschinsky |
The Journal of biological chemistry | 2015 |
Rhesus monkey ( Macaca mulatta ) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoforms
B Enkhmaa, A Abbuthalha, E Anuurad, W Zhang, AF Tarantal, L Berglund |
Journal of Medical Primatology | 2015 |
Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment: The Multi-Ethnic Study of Atherosclerosis
W Guan, J Cao, BT Steffen, WS Post, JH Stein, MC Tattersall, JD Kaufman, JP McConnell, DM Hoefner, R Warnick, MY Tsai |
Arteriosclerosis, thrombosis, and vascular biology | 2015 |
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
N Müller, DM Schulte, K Türk, S Freitag-Wolf, J Hampe, R Zeuner, JO Schröder, I Gouni-Berthold, HK Berthold, W Krone, S Rose-John, S Schreiber, M Laudes |
Journal of lipid research | 2015 |
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state
C Catena |
World Journal of Nephrology | 2015 |
High Lipoprotein(a) Concentrations Are Associated with Impaired Endothelial Function in Children
J Lapinleimu, OT Raitakari, H Lapinleimu, K Pahkala, T Rönnemaa, OG Simell, JS Viikari |
The Journal of Pediatrics | 2015 |
New and Emerging Biomarkers in Cardiovascular Disease
LE Cahill, ML Bertoia, SA Aroner, KJ Mukamal, MK Jensen |
Current Diabetes Reports | 2015 |
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study
J Li, LA Lange, J Sabourin, Q Duan, W Valdar, MS Willis, Y Li, JG Wilson, EM Lange |
Journal of Human Genetics | 2015 |
Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People – Data from the Berlin Aging Study II
N Buchmann, U Kassner, K Norman, D Goldeck, R Eckardt, G Pawelec, E Steinhagen-Thiessen, I Demuth, CM Schooling |
PloS one | 2015 |
Quantitative variability of 342 plasma proteins in a human twin population
Y Liu, A Buil, BC Collins, LC Gillet, LC Blum, LY Cheng, O Vitek, J Mouritsen, G Lachance, TD Spector, ET Dermitzakis, R Aebersold |
Molecular Systems Biology | 2015 |
Distinct Metabolism of Apolipoproteins (a) and B-100 within Plasma Lipoprotein(a)
MR Diffenderfer, S Lamon-Fava, SM Marcovina, PH Barrett, J Lel, GG Dolnikowski, L Berglund, EJ Schaefer |
Metabolism | 2015 |
Lipoprotein (a) is a risk factor for coronary artery disease in Chinese Han ethnic population modified by some traditional risk factors: A cross-sectional study of 3462 cases and 6125 controls
DP Cai, YM He, XJ Yang, X Zhao, HF Xu |
Clinica Chimica Acta | 2015 |
Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians
M Khalifa, A Noureen, K Ertelthalner, AR Bandegi, R Delport, WJ Firdaus, FS Geethanjali, K Luthra, O Makemaharn, RW Pang, AH Salem, J Sasaki, W Schiefenhoevel, A Lingenhel, F Kronenberg, G Utermann, K Schmidt |
Atherosclerosis | 2015 |
A sense of excitement for a specific Lp(a)-lowering therapy
ES Stroes, FM van der Valk |
The Lancet | 2015 |
Lipoprotein(a): Its relevance to the pediatric population
CJ McNeal |
Journal of Clinical Lipidology | 2015 |
Lipoprotein (a): impact by ethnicity and environmental and medical conditions
B Enkhmaa, E Anuurad, L Berglund |
Journal of lipid research | 2015 |
Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans
MJ Graham, N Viney, RM Crooke, S Tsimikas |
Journal of lipid research | 2015 |
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
MB Boffa, ML Koschinsky |
Journal of lipid research | 2015 |
Combination Therapy In Dyslipidemia
M Banach |
2015 | |
Dyslipidemias: Pathophysiology, Evaluation and Management
A Garg |
2015 | |
Recent advances in physiological lipoprotein metabolism
I Ramasamy |
Clinical Chemistry and Laboratory Medicine | 2014 |
Novel metabolic biomarkers of cardiovascular disease
MK Jensen, ML Bertoia, LE Cahill, I Agarwal, EB Rimm, KJ Mukamal |
Nature Reviews Endocrinology | 2014 |
The Association between the LPA Gene Polymorphism and Coronary Artery Disease in Chinese Han Population
ZK Song, HD Wu, HY Cao, L Qin |
BioMed Research International | 2014 |
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African–Americans
B Enkhmaa, E Anuurad, W Zhang, L Berglund |
Atherosclerosis | 2014 |
Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry: Characterization of apolipoprotein(a) by UPLC/MS
ME Lassman, TM McLaughlin, H Zhou, Y Pan, SM Marcovina, O Laterza, TP Roddy |
Rapid communications in mass spectrometry : RCM | 2014 |
Managing Cardiovascular Complications in Diabetes: Betteridge/Managing Cardiovascular Complications in Diabetes
A Lansdown, E Ellins, J Halcox |
Managing Cardiovascular Complications in Diabetes: Betteridge/Managing Cardiovascular Complications in Diabetes | 2014 |
Prognostic value of serum lipoprotein(a) levels in patients with acute ischemic stroke:
W Zhang, XA Zhang |
NeuroReport | 2014 |
Critical review of non-statin treatments for dyslipoproteinemia
J Pang, DC Chan, GF Watts |
Expert Review of Cardiovascular Therapy | 2014 |
New and Emerging Risk Factors for Coronary Heart Disease:
E Akhabue, J Thiboutot, J Cheng, TJ Vittorio, G Christodoulidis, KM Grady, S Lerakis, CE Kosmas |
The American Journal of the Medical Sciences | 2014 |
Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype
A Cenarro, J Puzo, J Ferrando, R Mateo-Gallego, AM Bea, P Calmarza, E Jarauta, F Civeira |
Metabolism | 2014 |
Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk
A Langsted, PR Kamstrup, BG Nordestgaard |
Atherosclerosis | 2014 |
Genetic variants in PLG, LPA, and SIGLEC 14 as well as smoking contribute to plasma plasminogen levels
Q Ma, AB Ozel, S Ramdas, B McGee, R Khoriaty, D Siemieniak, HD Li, Y Guan, LC Brody, JL Mills, AM Molloy, D Ginsburg, JZ Li, KC Desch |
Blood | 2014 |
Lipoprotein(a)
ML Koschinsky, MB Boffa |
Endocrinology and metabolism clinics of North America | 2014 |
Genetics of coronary heart disease with reference to ApoAI-CIII-AIV gene region
S Agrawal |
World journal of cardiology | 2014 |
Evolving targets for lipid-modifying therapy
RQ Do, SJ Nicholls, GG Schwartz |
EMBO Molecular Medicine | 2014 |
Low birthweight and elevated levels of lipoprotein(a) in prepubertal children: Low birthweight and lipoprotein(a)
M Rodríguez-Moran, F Guerrero-Romero |
J Paediatr Child Health | 2014 |
Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)
R Romagnuolo, SM Marcovina, MB Boffa, ML Koschinsky |
Journal of lipid research | 2014 |
Lipoprotein (a): Structure, Pathophysiology and Clinical Implications
RC Maranhão, PO Carvalho, CC Strunz, F Pileggi |
Arquivos brasileiros de cardiologia | 2014 |
Relationships of Plasma Lipoprotein(a) Levels with Insulin Resistance in Hypertensive Patients
L Marzano, GL Colussi, MD Torre, LA Sechi, C Catena |
Metabolism | 2014 |
Copy number variation of the Lipoprotein(a) (LPA) gene is associated with coronary artery disease in a southern Han Chinese population
Zhijun Wu, Haihui Sheng, Yanjia Chen, Jing Tang, Yan Liu, Qiujing Chen, Lin Lu, Wei Jin |
International journal of clinical and experimental medicine | 2014 |
Dyslipidemias in Kidney Disease
A Covic, M Kanbay, EV Lerma |
2014 | |
Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator
MB Boffa, ML Koschinsky |
Current Atherosclerosis Reports | 2013 |
Lack of association between carotid intima-media thickness and apolipoprotein (a) isoforms in a sample of Spanish general population
P Calmarza, JM Trejo, C Lapresta, P Lopez |
Journal of Cardiology | 2013 |
eLS
YC Chang, YH Yu, LM Chuang |
Encyclopedia of Life Sciences | 2013 |
When should we measure lipoprotein (a)?
KM Kostner, W Marz, GM Kostner |
European Heart Journal | 2013 |
Lipoprotein(a): a promising marker for residual cardiovascular risk assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou |
Disease Markers | 2013 |
Screening for and Management of Elevated Lp(a)
MB Boffa, ML Koschinsky |
Current Cardiology Reports | 2013 |
The Relationship Between Serum Lipoprotein (a) Levels and Ischemic Stroke Risk: A Cohort Study in the Chinese Population
S Li, Y Gao, W Ma, H Wang, G Zhou, W Guo, Y Liu |
Inflammation | 2013 |
Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21483 women
JS Danik, JE Buring, DI Chasman, RY Zee, PM Ridker, RJ Glynn |
Journal of Thrombosis and Haemostasis | 2013 |
Lipoprotein(a) plasma levels and the risk of cancer: the PRIME study
É Marrer, A Wagner, M Montaye, G Luc, P Amouyel, J Dallongeville, P Ducimetiere, A Bingham, D Arveiler, M Velten |
European Journal of Cancer Prevention | 2013 |
Lipoprotein(a): epidemiology, atherogenic activity and impact on cardiovascular risk
BA Phan, PP Toth |
Clinical Lipidology | 2013 |
Lipoprotein(a) metabolism: Potential sites for therapeutic targets
J Hoover-Plow, M Huang |
Metabolism | 2012 |
Carotid Intima-Media Thickness in Asymptomatic Subjects With Low Lipoprotein(a) Levels
K Kotani, N Sakane |
Journal of clinical medicine research | 2012 |
Lipoprotein(a) and cardiovascular disease in diabetic patients
Q Qi, L Qi |
Clinical Lipidology | 2012 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Lipid, lipoprotein and apolipoprotein profiles in European adolescents and its associations with gender, biological maturity and body fat—The HELENA Study
A Spinneker, S Egert, M González-Gross, C Breidenassel, U Albers, B Stoffel-Wagner, I Huybrechts, Y Manios, E Venneria, D Molnar, K Widhalm, L Moreno, P Stehle |
European Journal of Clinical Nutrition | 2012 |
Lipoprotein(a) : more interesting than ever after 50 years
JB Dubé, MB Boffa, RA Hegele, ML Koschinsky |
Current Opinion in Lipidology | 2012 |
Genetics of coronary artery disease: Genome-wide association studies and beyond
BP Prins, V Lagou, FW Asselbergs, H Snieder, J Fu |
Atherosclerosis | 2012 |
MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis
F Lu, X Zhao, J Wu, Y Cui, Y Mao, K Chen, Y Yuan, D Gong, Z Xu, S Huang |
International Journal of Cardiology | 2012 |
Lipoprotein(a), Ferritin, and Albumin in Acute Phase Reaction Predicts Severity and Mortality of Acute Ischemic Stroke in North Indian Patients
B Chakraborty, G Vishnoi, B Goswami, SH Gowda, D Chowdhury, S Agarwal |
Journal of Stroke and Cerebrovascular Diseases | 2012 |
Lipoprotein(a): resurrected by genetics
F Kronenberg, G Utermann |
Journal of Internal Medicine | 2012 |
Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study
X Lv, Y Zhang, S Rao, F Liu, X Zuo, D Su, M Wang, M Xia, H Guo, D Feng, C Hong, D Li, W Ma, P Ouyang, X Li, X Feng, Y Yang, W Ling, J Qiu |
Lipids in Health and Disease | 2012 |
Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients
L Egaña-Gorroño, E Martínez, T Escribà, M Calvo, JM Gatell, M Arnedo |
Frontiers in immunology | 2012 |
High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: results of a cross-sectional epidemiological survey in Gran Canaria, Spain
M Boronat, P Saavedra, N Pérez-Martín, MJ López-Madrazo, C Rodríguez-Pérez, FJ Nóvoa |
Cardiovascular Diabetology | 2012 |
HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels
B Enkhmaa, E Anuurad, W Zhang, A Abbuthalha, XD Li, W Dotterweich, RB Pollard, DM Asmuth, L Berglund |
Arteriosclerosis, thrombosis, and vascular biology | 2012 |
Dyslipidaemia in rheumatological autoimmune diseases
TE Toms, VF Panoulas, GD Kitas |
The open cardiovascular medicine journal | 2011 |
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
The Incremental Value of Lipids and Inflammatory Biomarkers in Determining Residual Cardiovascular Risk
SS Mangalmurti, MH Davidson |
Current Atherosclerosis Reports | 2011 |
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
MS Nenseter, HW Lindvig, T Ueland, G Langslet, L Ose, KB Holven, K Retterstøl |
Atherosclerosis | 2011 |
Lipoprotein (a): Perspectives from a lipid-referral program
M Rubenfire, D Vodnala, SM Krishnan, RL Bard, EA Jackson, D Giacherio, RD Brook |
Journal of Clinical Lipidology | 2011 |
Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft
P Song, JM Seok, WS Kim, YT Lee, DK Kim, GM Kim |
Atherosclerosis | 2011 |
Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women
P Wennberg, F Wensley, ED Angelantonio, L Johansson, K Boman, A Rumley, G Lowe, G Hallmans, J Danesh, JH Jansson |
Thrombosis Research | 2011 |
Lipoprotein(a) and Family History of Cardiovascular Disease in Children with Familial Dyslipidemias
O Guardamagna, F Abello, G Anfossi, M Pirro |
The Journal of Pediatrics | 2011 |
Lipoprotein(a) and the risk of thromboembolism in Thai children
N Sirachainan, C Chaiyong, A Visudtibhan, W Sasanakul, S Osatakul, P Wongwerawattanakoon, P Kadegasem, A Chuansumrit |
Thrombosis Research | 2011 |
Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism
M Konerman, K Kulkarni, PP Toth, SR Jones |
Journal of Clinical Lipidology | 2011 |
Differential Associations of Serum Amyloid A and Pentraxin-3 with Allele-Specific Lipoprotein(a) Levels in African Americans and Caucasians
B Enkhmaa, E Anuurad, Z Ozturk, W Zhang, TA Pearson, L Berglund |
Translational research : the journal of laboratory and clinical medicine | 2011 |
Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
M Uccello, G Malaguarnera, EM Pelligra, A Biondi, F Basile, M Motta |
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology | 2011 |
A Comparison of Approaches to Control for Confounding Factors by Regression Models
G Xing, CY Lin, C Xing |
Human Heredity | 2011 |
Lipoprotein(a): Reloaded
F Kronenberg, G Utermann |
Current Cardiovascular Risk Reports | 2011 |
Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14,500 participants of six White European cohorts
D Zabaneh, M Kumari, M Sandhu, N Wareham, N Wainwright, T Papamarkou, J Hopewell, R Clarke, KW Li, J Palmen, PJ Talmud, F Kronenberg, C Lamina, M Summerer, B Paulweber, J Price, G Fowkes, M Stewart, F Drenos, S Shah, T Shah, JP Casas, M Kivimaki, J Whittaker, AD Hingorani, SE Humphries |
Atherosclerosis | 2011 |
Lipoprotein(a): Genotype–Phenotype Relationship and Impact on Atherogenic Risk
B Enkhmaa, E Anuurad, W Zhang, T Tran, L Berglund |
Metabolic Syndrome and Related Disorders | 2011 |
Sex hormones and lipoprotein(a) concentration
G Gaeta, S Lanero, S Barra, N Silvestri, V Cuomo, C Materazzi, G Vitagliano |
Expert Opinion on Investigational Drugs | 2011 |
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
S Lamon-Fava, SM Marcovina, JJ Albers, H Kennedy, C DeLuca, CC White, LA Cupples, JR McNamara, LJ Seman, V Bongard, EJ Schaefer |
Journal of lipid research | 2011 |
Single-Nucleotide Polymorphisms in LPA Explain Most of the Ancestry-Specific Variation in Lp(a) Levels in African Americans
RC Deo, JG Wilson, C Xing, K Lawson, WH Kao, D Reich, A Tandon, E Akylbekova, N Patterson, TH Mosley, E Boerwinkle, HA Taylor, JK Pritchard |
PloS one | 2011 |
Variation in LPA Is Associated with Lp(a) Levels in Three Populations from the Third National Health and Nutrition Examination Survey
L Dumitrescu, K Glenn, K Brown-Gentry, C Shephard, M Wong, MJ Rieder, JD Smith, DA Nickerson, DC Crawford, A Kloss-Brandstaetter |
PloS one | 2011 |
Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk
J Ronald, R Rajagopalan, F Cerrato, AS Nord, T Hatsukami, T Kohler, S Marcovina, P Heagerty, GP Jarvik |
Stroke; a journal of cerebral circulation | 2011 |
Estrogen attenuates vascular remodeling in Lp(a) transgenic mice
F Nakagami, H Nakagami, MK Osako, M Iwabayashi, Y Taniyama, T Doi, H Shimizu, M Shimamura, H Rakugi, R Morishita |
Atherosclerosis | 2010 |
Association of Lp-PLA2 activity with allele-specific Lp(a) levels in a bi-ethnic population
B Enkhmaa, E Anuurad, W Zhang, TA Pearson, L Berglund |
Atherosclerosis | 2010 |
Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus
D Shiffman, JZ Louie, CM Rowland, MJ Malloy, JP Kane, JJ Devlin |
Atherosclerosis | 2010 |
Apolipoprotein(a) Isoforms and the Risk of Vascular Disease
S Erqou, A Thompson, ED Angelantonio, D Saleheen, S Kaptoge, S Marcovina, J Danesh |
Journal of the American College of Cardiology | 2010 |
Translating genomic analyses into improved management of coronary artery disease
CT Johansen, MB Lanktree, RA Hegele |
Future Cardiology | 2010 |
An Elevated Level of Physical Activity Is Associated With Normal Lipoprotein(a) Levels in Individuals From Maracaibo, Venezuela
V Bermúdez, D Aparicio, E Rojas, L Peñaranda, F Finol, L Acosta, E Mengual, J Rojas, N Arráiz, A Toledo, C Colmenares, J Urribarí, W Sanchez, C Pineda, D Rodriguez, J Faria, R Añez, R Cano, C Cano, L Sorell, M Velasco |
American Journal of Therapeutics | 2010 |
Leptin is associated with the size of the apolipoprotein(a) particle in African tribal populations living on fish or vegetarian diet
M Winnicki, M Puato, VK Somers, A Zambon, SM Marcovina, M Rattazzi, BG Phillips, P Pauletto |
Atherosclerosis | 2010 |
Effects of Ezetimibe on Remnant-Like Particle Cholesterol, Lipoprotein (a), and Oxidized Low-Density Lipoprotein in Patients with Dyslipidemia
T Nozue, I Michishita, I Mizuguchi |
Journal of Atherosclerosis and Thrombosis | 2010 |
Management of Lp(a)†
WV Brown, CM Ballantyne, PH Jones, S Marcovina |
Journal of Clinical Lipidology | 2010 |
Extremely elevated lipoprotein(a), combined hyperlipidemia, and premature atherosclerosis in a Chinese family
EM deGoma, MT Wheeler, SM Marcovina, EA Ashley |
Journal of Clinical Lipidology | 2010 |
The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles
K Arai, MM Luke, ML Koschinsky, ER Miller, CR Pullinger, JL Witztum, JP Kane, S Tsimikas |
Atherosclerosis | 2010 |
Formes rares de dyslipidémies génétiques
G Luc |
EMC - Endocrinologie - Nutrition | 2010 |
Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet
N Faghihnia, S Tsimikas, ER Miller, JL Witztum, RM Krauss |
Journal of lipid research | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Genetic basis of myocardial infarction: Novel insights from genome-wide association studies
J Erdmann, P Linsel-Nitschke, H Schunkert |
Current Cardiovascular Risk Reports | 2009 |
Antiphospholipid antibodies and lipoprotein(a) in obese children
D Pascut, T Princi, M Donato, G Tamaro, S Parco |
Acta Paediatrica | 2009 |
All-Cause Mortality and Competing Risks of Fatal and Nonfatal Vascular Events in the Italian Longitudinal Study on Aging: Impact of Lipoprotein(a)
V Solfrizzi, AM Colacicco, A D'Introno, C Capurso, M Chirico, V Frisardi, M Cacciapaglia, G Vendemiale, A Capurso, F Panza |
Rejuvenation Research | 2009 |
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease
DA Trégouët, IR König, J Erdmann, A Munteanu, PS Braund, AS Hall, A Großhennig, P Linsel-Nitschke, C Perret, M DeSuremain, T Meitinger, BJ Wright, M Preuss, AJ Balmforth, SG Ball, C Meisinger, C Germain, A Evans, D Arveiler, G Luc, JB Ruidavets, C Morrison, P der Harst, S Schreiber, K Neureuther, A Schäfer, P Bugert, NE el Mokhtari, J Schrezenmeir, K Stark, D Rubin, HE Wichmann, C Hengstenberg, W Ouwehand, A Ziegler, L Tiret, JR Thompson, F Cambien, H Schunkert, NJ Samani |
Nature Genetics | 2009 |
Lipoprotein a: where are we now?
K Tziomalos, VG Athyros, AS Wierzbicki, DP Mikhailidis |
Current Opinion in Cardiology | 2009 |
Lipoprotein(a): a causal independent risk factor for coronary heart disease?
V Gudnason |
Current Opinion in Cardiology | 2009 |
Mendelian randomization: nature's randomized trial in the post-genome era
G Thanassoulis, CJ O'Donnell |
Journal of the American Medical Association | 2009 |
The apo(a) gene (TTTTA)n promoter polymorphism and its association with variability in exons of the kringle IV types 8 to 10
K Hirschfeldova, D Lipovska, P Skrha, R Ceska |
Clinica Chimica Acta | 2009 |
Designing a study to evaluate the effect of apheresis in patients with elevated lipoprotein(a)
U Kassner, A Vogt, A Rosada, F Barz, E Giannakidou-Jordan, HK Berthold, E Steinhagen-Thiessen |
Atherosclerosis Supplements | 2009 |
Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus
F Galvano, GL Volti, M Malaguarnera, T Avitabile, T Antic, M Vacante, M Malaguarnera |
Expert Opinion on Pharmacotherapy | 2009 |
Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q
C Ober, AS Nord, EE Thompson, L Pan, Z Tan, D Cusanovich, Y Sun, R Nicolae, C Edelstein, DH Schneider, C Billstrand, D Pfaffinger, N Phillips, RL Anderson, B Philips, R Rajagopalan, TS Hatsukami, MJ Rieder, PJ Heagerty, DA Nickerson, M Abney, S Marcovina, GP Jarvik, AM Scanu, DL Nicolae |
Journal of lipid research | 2009 |
Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons
DL Rainwater, LA Cox, J Rogers, JL VandeBerg, MC Mahaney |
Journal of lipid research | 2009 |
Population-Based Genomewide Genetic Analysis of Common Clinical Chemistry Analytes
DI Chasman, G Paré, PM Ridker |
Clinical chemistry | 2009 |
Handbook on Analyzing Human Genetic Data
S Lin, H Zhao |
2009 | |
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease
DA Trégouët, IR König, J Erdmann, A Munteanu, PS Braund, AS Hall, A Großhennig, P Linsel-Nitschke, C Perret, M DeSuremain, T Meitinger, BJ Wright, M Preuss, AJ Balmforth, SG Ball, C Meisinger, C Germain, A Evans, D Arveiler, G Luc, JB Ruidavets, C Morrison, P van der Harst, S Schreiber, K Neureuther, A Schäfer, P Bugert, NE Mokhtari, J Schrezenmeir, K Stark, D Rubin, HE Wichmann, C Hengstenberg, W Ouwehand, A Ziegler, L Tiret, JR Thompson, F Cambien, H Schunkert, NJ Samani |
Nature Genetics | 2009 |
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J |
Journal of the American Medical Association | 2009 |
The apolipoprotein(a) gene: Linkage disequilibria at three loci differs in African Americans and Caucasians
J Rubin, HJ Kim, TA Pearson, S Holleran, L Berglund, R Ramakrishnan |
Atherosclerosis | 2008 |
Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels
S López, A Buil, J Ordoñez, JC Souto, L Almasy, M Lathrop, J Blangero, F Blanco-Vaca, J Fontcuberta, JM Soria |
European Journal of Human Genetics | 2008 |
Lipoprotein (a) erhöht das Infarktrisiko
T Hucko, K Graf |
Der Kardiologe | 2008 |
Apoprotein(A) Isoforms and Plasma LP(A) Concentration in Members of Four Families
D Labudovik, K Tosheska, S Alabakovska, J Bogdanska, BB Todorova |
Journal of Medical Biochemistry | 2008 |
Lipoprotein(a) and coronary artery disease: Ongoing debate
T Celik, C Yuksel, A Iyisoy, E Isik |
Nutrition, Metabolism and Cardiovascular Diseases | 2008 |
Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome
A Onat, G Hergenç, H Özhan, Z Kaya, S Bulur, E Ayhan, G Can |
Coronary Artery Disease | 2008 |
Aggregation of lipoprotein and inflammatory parameters in families with a history of premature myocardial infarction: the Tallinn Myocardial Infarction Study
K Aasvee, E Kurvinen, J Sundvall, M Jauhiainen, I Tur |
Clinical Chemistry and Laboratory Medicine | 2008 |
LPA and PLG sequence variation and kringle IV-2 copy number in two populations
DC Crawford, Z Peng, JF Cheng, D Boffelli, M Ahearn, D Nguyen, T Shaffer, Q Yi, RJ Livingston, MJ Rieder, DA Nickerson |
Human Heredity | 2008 |
Lipoprotein(a), homocysteine, and retinal arteriosclerosis
A Ghorbanihaghjo, A Javadzadeh, H Argani, N Nezami, N Rashtchizadeh, M Rafeey, M Rohbaninoubar, B Rahimi-Ardabili |
Molecular vision | 2008 |
Relationship between apo(a) length polymorphism and lipoprotein(a) concentration in healthy Ivorian subjects with single or double apo(a) isoforms
A Edjème-Aké, R Garnotel, S Vallée-Polneau, E Anglés-Cano, D Monnet, P Gillery |
Clinical Biochemistry | 2008 |
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians
JK Gambhir, H Kaur, KM Prabhu, JD Morrisett, DS Gambhir |
Clinical Biochemistry | 2008 |
The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease
M Catalano, A Cortelazzo, Y Yilmaz, E Perilli, G Carzaniga, E Emanuele |
Clinica Chimica Acta | 2008 |
Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR
MB Lanktree, C Rajakumar, JH Brunt, ML Koschinsky, PW Connelly, RA Hegele |
Journal of lipid research | 2008 |
A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)
D Melzer, JR Perry, D Hernandez, AM Corsi, K Stevens, I Rafferty, F Lauretani, A Murray, JR Gibbs, G Paolisso, S Rafiq, J Simon-Sanchez, H Lango, S Scholz, MN Weedon, S Arepalli, N Rice, N Washecka, A Hurst, A Britton, W Henley, J de Leemput, R Li, AB Newman, G Tranah, T Harris, V Panicker, C Dayan, A Bennett, MI McCarthy, A Ruokonen, MR Jarvelin, J Guralnik, S Bandinelli, TM Frayling, A Singleton, L Ferrucci, VG Cheung |
PLoS genetics | 2008 |
Bioinformatics
JM Keith |
Bioinformatics | 2008 |
Therapeutic Lipidology
MH Davidson, PP Toth, KC Maki, AM Gotto |
2008 | |
FULL TEXT Chapter 1: Introduction
&NA; |
European Journal of Cardiovascular Prevention & Rehabilitation | 2007 |
Lipoproteins, Vascular-Related Genetic Factors, and Human Longevity
F Panza, A D'introno, C Capurso, AM Colacicco, D Seripa, A Pilotto, A Santamato, A Capurso, V Solfrizzi |
Rejuvenation Research | 2007 |
Heritability estimation of sex-specific effects on human quantitative traits
L Pan, C Ober, M Abney |
Genetic Epidemiology | 2007 |
LPA +93C>T and +121G>A polymorphisms detection by electronic microchip technology
E Sticchi, M Lenti, B Giusti, I Sestini, R Abbate, C Fatini |
Molecular Genetics and Metabolism | 2007 |
Fish intake and LPA 93C>T polymorphism: Gene-environment interaction in modulating lipoprotein (a) concentrations
F Sofi, C Fatini, E Sticchi, M Lenti, AM Gori, B Giusti, S Fedi, A Casini, R Abbate, GF Gensini |
Atherosclerosis | 2007 |
Lipoprotein profile in Arabian type 2 diabetic patients. Relationship to coronary artery diseases
MH Daghash, A Bener, M Zirie, W Dabdoob, AO Al-Hamaq, ZA Al-Arabi |
International Journal of Cardiology | 2007 |
Detection of variability in apo(a) gene transcription regulatory sequences using the DGGE method
K Zídková, V Kebrdlová, L Zlatohlávek, R Češka |
Clinica Chimica Acta | 2007 |
Increased Serum Lipoprotein(a) Concentrations and Low Molecular Weight Phenotypes of Apolipoprotein(a) Are Associated with Symptomatic Peripheral Arterial Disease
B Dieplinger, A Lingenhel, N Baumgartner, W Poelz, H Dieplinger, M Haltmayer, F Kronenberg, T Mueller |
Clinical chemistry | 2007 |
Plasma Lipoprotein(a) Indicates Risk for 4 Distinct Forms of Vascular Disease
GT Jones, AM van Rij, J Cole, MJ Williams, EH Bateman, SM Marcovina, M Deng, SP McCormick |
Clinical chemistry | 2007 |
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals
HJ Milionis, TD Filippatos, T Loukas, ET Bairaktari, AD Tselepis, MS Elisaf |
Atherosclerosis | 2006 |
Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS study
S Barlera, C Specchia, M Farrall, BD Chiodini, MG Franzosi, S Rust, F Green, EB Nicolis, J Peden, G Assmann, R Collins, A Hamsten, G Tognoni, H Watkins |
European Journal of Human Genetics | 2006 |
Efficacy and tolerability of combined treatment with l-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus
V Solfrizzi, C Capurso, AM Colacicco, A D’Introno, C Fontana, SA Capurso, F Torres, AM Gadaleta, A Koverech, A Capurso, F Panza |
Atherosclerosis | 2006 |
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans
JP Chretien, J Coresh, Y Berthier-Schaad, WH Kao, NE Fink, MJ Klag, SM Marcovina, F Giaculli, MW Smith |
Journal of medical genetics | 2006 |
Electroelution of lipoprotein(a) [Lp(a)] from native polyacrylamide gels: A new, simple method to purify Lp(a)
B Chellan, PS Appukuttan, N Jayakumari |
Journal of Biochemical and Biophysical Methods | 2006 |
Elevated Lipoprotein(a)—A Genetic Risk Factor for Premature Vascular Disease in People With and Without Standard Risk Factors: A Review
EA Enas, V Chacko, A Senthilkumar, N Puthumana, V Mohan |
Disease-a-Month | 2006 |
Ethnicity and lipoprotein(a) polymorphism in Native Mexican populations
G Cardoso-Saldaña, AD la Peña-Díaz, J Zamora-González, R Gomez-Ortega, C Posadas-Romero, R Izaguirre-Avila, E Malvido-Miranda, ME Morales-Anduaga, E Anglés-Cano |
Annals of Human Biology | 2006 |
Determinants of risk factors of atherosclerosis in the postinfarction period: The Tallinn MI Study
K Aasvee, M Jauhiainen, E Kurvinen, I Tur, J Sundvall, T Roovere, A Baburin |
Scandinavian Journal of Clinical & Laboratory Investigation | 2006 |
Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]
J Rubin, HJ Kim, TA Pearson, S Holleran, R Ramakrishnan, L Berglund |
Journal of lipid research | 2006 |
ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study
E Anuurad, G Lu, J Rubin, TA Pearson, L Berglund |
Journal of lipid research | 2006 |
Heritable Components of Feline Hematology, Clinical Chemistry, and Acid–Base Profiles
DF Lawler, K Chase, R Teckenbrock, KG Lark |
Journal of Heredity | 2006 |
Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein
ML Koschinsky |
Current Atherosclerosis Reports | 2005 |
Lipoprotein(a): Implications for clinical practice
RC Block, TA Pearson |
Current Atherosclerosis Reports | 2005 |
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes
I Shai, MB Schulze, JE Manson, MJ Stampfer, N Rifai, FB Hu |
Diabetologia | 2005 |
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a)
C Catena, M Novello, R Lapenna, S Baroselli, G Colussi, E Nadalini, G Favret, A Cavarape, G Soardo, LA Sechi |
Journal of Hypertension | 2005 |
A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study
JA Cooper, GJ Miller, SE Humphries |
Atherosclerosis | 2005 |
Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon
K Schmidt, HG Kraft, W Parson, G Utermann |
European Journal of Human Genetics | 2005 |
High fidelity screening of regulatory sequences in apolipoprotein(a)-plasminogen cluster
X Lv, HZ Shi, DP Liu, DL Hao, S Zhang, L Xin, XG Li, HM Xu, CC Liang |
The International Journal of Biochemistry & Cell Biology | 2005 |
Associations of middle-aged mother's but not father's body mass index with 18-year-old son's waist circumferences, birth weight, and serum hepatic enzyme levels
T Kazumi, A Kawaguchi, G Yoshino |
Metabolism | 2005 |
Factors associated with lipoprotein(a) in chronic kidney disease
K Uhlig, SR Wang, GJ Beck, JW Kusek, SM Marcovina, T Greene, AS Levey, MJ Sarnak |
American Journal of Kidney Diseases | 2005 |
Conditional Risk Factors for Atherosclerosis
IJ Kullo, CM Ballantyne |
Mayo Clinic Proceedings | 2005 |
Serum lipid and apolipoprotein profiles in newborns and six‐year‐old children: The Tallinn Young Family Study
E Kurvinen, K Aasvee, R Zordania, M Jauhiainen, J Sundvall |
Scandinavian Journal of Clinical & Laboratory Investigation | 2005 |
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
I Shai, EB Rimm, SE Hankinson, C Cannuscio, G Curhan, JA Manson, N Rifai, MJ Stampfer, J Ma |
European Heart Journal | 2005 |
Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels
PT Williams, PJ Blanche, R Rawlings, RM Krauss |
The American journal of clinical nutrition | 2005 |
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease
LD Tsironis, CS Katsouras, ES Lourida, JV Mitsios, J Goudevenos, M Elisaf, AD Tselepis |
Atherosclerosis | 2004 |
A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a)
W Parson, HG Kraft, H Niederst�tter, AW Lingenhel, S K�chl, F Fresser, G Utermann |
Human Mutation | 2004 |
The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients
AC Jansen, ES Aalst-Cohen, MW Tanck, MD Trip, PJ Lansberg, AH Liem, HW van Lennep, EJ Sijbrands, JJ Kastelein |
Journal of Internal Medicine | 2004 |
Geriatric depression and vascular diseases: what are the links?
V Camus, H Kraehenbühl, M Preisig, CJ Büla, G Waeber |
Journal of Affective Disorders | 2004 |
Convergent evolution in primates and an insectivore
D Boffelli, JF Cheng, EM Rubin |
Genomics | 2004 |
GENETICS OF ATHEROSCLEROSIS
AJ Lusis, R Mar, P Pajukanta |
Annual Review of Genomics and Human Genetics | 2004 |
Do gene-environment interactions influence fasting plasma lipids? A study of twins
JR Greenfield, K Samaras, AB Jenkins, PJ Kelly, TD Spector, LV Campbell |
European Journal of Clinical Investigation | 2004 |
A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription
S Negi, SK Singh, N Pati, V Handa, R Chauhan, U Pati |
Biochemical Journal | 2004 |
Lipids and lipoprotein(a) concentrations in Tunisian type 2 diabetic patients
M Smaoui, S Hammami, R Chaaba, N Attia, KB Hamda, AS Masmoudi, S Mahjoub, A Bousslama, MB Farhat, M Hammami |
Journal of Diabetes and its Complications | 2004 |
El fenotipo de lipoproteína(a): ¿un marcador genético de enfermedad coronaria?
JJ Gómez-Barrado, S Turégano, JC García-Rubira, JM Cruz |
Clínica e Investigación en Arteriosclerosis | 2004 |
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation
E Emanuele, E Peros, P Minoretti, A D'Angelo, L Montagna, C Falcone, D Geroldi |
Clinica Chimica Acta | 2004 |
Metabolic and nutritional aspects of the atherogenic atypical lipoproteins: Lipoprotein(a), remnant lipoproteins, and oxidized low-density lipoprotein
WJ Castellani |
Nutrition Research | 2004 |
Discrepancy of interleukin‐6 levels between end‐stage renal disease patients and patients with acute‐phase response with increased lipoprotein(a) concentrations
KA Yun, W Lee, WK Min, S Chun, YW Lee, SB Kim, JS Park, WS Yang, H Park, SH Hwang |
Scandinavian Journal of Clinical & Laboratory Investigation | 2004 |
Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study
K Aasvee, E Kurvinen, R Jordania, M Jauhiainen, J Sundvall |
Scandinavian Journal of Clinical & Laboratory Investigation | 2004 |
Meat‐Adaptive Genes and the Evolution of Slower Aging in Humans
CE Finch, CB Stanford |
The Quarterly Review of Biology | 2004 |
Genetic and Plasma Markers of Venous Thromboembolism in Patients with High Grade Glioma
FL Sciacca, E Ciusani, A Silvani, E Corsini, S Frigerio, S Pogliani, E Parati, D Croci, A Boiardi, A Salmaggi |
Clinical cancer research | 2004 |
Nutrition and Alcohol
R Rylander |
Nutrition and Alcohol | 2003 |
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
GD Backer, E Ambrosioni, K Broch-Johnsen, C Brotons, R Cifkova, J Dallongeville, S Ebrahim, O Faergeman, I Graham, G Mancia, VM Cats, K Orth-Gom??r, J Perk, K Py??r??l??, JL Rodicio, S Sans, V Sansoy, U Sechtem, S Silber, T Thomsen, D Wood |
European Journal of Cardiovascular Prevention and Rehabilitation | 2003 |
Serum Lipoprotein(a) Concentration and Apo(a) Isoform under The Condition of Renal Dysfunction
M Kuboyama, M Ageta, T Ishihara, Y Fujiura, N Kashio, I Ikushima |
Journal of Atherosclerosis and Thrombosis | 2003 |
Serum lipoprotein(a) concentrations and alcohol consumption in hypertension
C Catena, M Novello, L Dotto, SD Marchi, LA Sechi |
Journal of Hypertension | 2003 |
Study of Apo(a) Length Polymorphism and Lipoprotein(a) Concentrations in Subjects with Single or Double Apo(a) Isoforms
M Alaoui, C Merle, R Garnotel, D Jolly, V Durlach, P Gillery |
Clinical Chemistry and Laboratory Medicine | 2003 |
Sequence and functional changes in a putative enhancer region upstream of the apolipoprotein(a) gene
LH Puckey, BL Knight |
Atherosclerosis | 2003 |
Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease
FS Geethanjali, K Luthra, A Lingenhel, AS Kanagasaba-Pathy, J Jacob, LM Srivastava, S Vasisht, HG Kraft, G Utermann |
Atherosclerosis | 2003 |
Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle Heart Project
A Tavridou, N Unwin, R Bhopal, MF Laker |
European Journal of Clinical Investigation | 2003 |
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
PR de Nolting, JC Defesche, RJ Buirma, BA Hutten, PJ Lansberg, JJ Kastelein |
Journal of Internal Medicine | 2003 |
Pentanucleotide TTTTA and G/A –914 DNA Polymorphisms in Apolipoprotein(a) Promoter: Genotyping by Single-Tube PCR
M Živković, A Stanković, D Alavantić |
Clinical Chemistry and Laboratory Medicine | 2003 |
Lipoprotein (a) and Apolipoprotein (a) Isoform Size in Thyroid Disease: The Quest for the Golden Fleece
LH Duntas |
Thyroid | 2003 |
Lipoprotein (a) Levels and Apolipoprotein (a) Isoform Size in Patients with Subclinical Hypothyroidism: Effect of Treatment with Levothyroxine
HJ Milionis, Z Efstathiadou, AD Tselepis, ET Bairaktari, LD Tsironis, A Tsatsoulis, MS Elisaf |
Thyroid | 2003 |
Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents
A Psyrogiannis, I Habeos, V Kyriazopoulou |
Lipids in Health and Disease | 2003 |
Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability
D Noto, A Pace, AB Cefalù, CM Barbagallo, M Rizzo, G Marino, G Emmanuele, S Travali, A Notarbartolo, M Averna |
Clinica Chimica Acta | 2003 |
Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans
E Emanuele |
Neuroscience Letters | 2003 |
Two-locus Linkage Analysis Applied to Putative Quantitative Trait Loci for Lipoprotein(a) Levels
M Beekman, BT Heijmans, NG Martin, JB Whitfield, NL Pedersen, U DeFaire, H Snieder, N Lakenberg, P Knijff, RR Frants, GJ van Ommen, C Kluft, GP Vogler, PE Slagboom, DI Boomsma |
Twin Research | 2003 |
Lipoprotein(a): An Emerging Cardiovascular Risk Factor
G Lippi, G Guidi |
Critical Reviews in Clinical Laboratory Sciences | 2003 |
Increased plasma adrenomedullin and serum lipoprotein (a) levels in patients with Behcet's disease
I Kocer, A Kiziltunc, S Taysi, A Yildirim |
The Pain Clinic | 2003 |
Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation
F Nassir, Y Xie, NO Davidson |
Journal of lipid research | 2003 |
Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids
BE Aouizerat, M Kulkarni, D Heilbron, D Drown, S Raskin, CR Pullinger, MJ Malloy, JP Kane |
Journal of lipid research | 2003 |
Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation
F Kronenberg, K Lhotta, P König, R Margreiter, H Dieplinger, G Utermann |
European Journal of Human Genetics | 2003 |
Subclinical Hypothyroidism and Lipid Abnormalities in Older Women Attending a Vascular Disease Prevention Clinic: Effect of Thyroid Replacement Therapy
ES Ganotakis, K Mandalaki, M Tampakaki, N Malliaraki, E Mandalakis, G Vrentzos, J Melissas, E Castanas |
Angiology | 2003 |
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
SM Marcovina, ML Koschinsky, JJ Albers, S Skarlatos |
Clinical chemistry | 2003 |
Role of Hypolipidemic Drug Clofibrate in Altering Iron Regulatory Proteins IRP1 and IRP2 Activities and Hepatic Iron Metabolism in Rats Fed a Low-Iron Diet
HL Huang, NS Shaw |
Toxicology and Applied Pharmacology | 2002 |
Hormonal influences on lipoprotein(a) metabolism
RW Pang, KS Lam |
Diabetes, Obesity and Metabolism | 2002 |
Searching for the mountains of the moon: Genome scans for atherosclerosis
MA Province |
Current Atherosclerosis Reports | 2002 |
Lipid profile during rhGH therapy in pediatric renal transplant patients
L Ghio, B Damiani, R Garavaglia, G Oppizzi, E Taioli, A Edefonti |
Pediatric Transplantation | 2002 |
Relation of Apolipoprotein (a) Phenotypes to Diabetic Retinopathy in Elderly Type 2 Diabetes
T Suzuki, K Oba, Y Igari, N Matsumura, Y Inuzuka, Y Kigawa, Y Matsuura, Y Ajiro, K Okazaki, H Nakano |
Journal of Nippon Medical School | 2002 |
Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk
S Gonbert, S Malinsky, AC Sposito, H Laouenan, C Doucet, MJ Chapman, J Thillet |
Atherosclerosis | 2002 |
Growth hormone deficiency and vascular risk
RW McCallum, JR Petrie, AF Dominiczak, JM Connell |
Clinical Endocrinology | 2002 |
Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly
C Parkinson, WM Drake, G Wieringa, AP Yates, GM Besser, PJ Trainer |
Clinical Endocrinology | 2002 |
Radical trapping in glycogen storage disease 1a
B Wittenstein, M Klein, B Finckh, K Ullrich, A Kohlschütter |
European Journal of Pediatrics | 2002 |
Lipoprotein(a) as a potent risk indicator for early cardiovascular disease
A Dirisamer, K Widhalm |
Acta Paediatrica | 2002 |
Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia
B Wittenstein, M Klein, B Finckh, K Ullrich, A Kohlschütter |
Free radical biology & medicine | 2002 |
SERUM LIPOPROTEIN(A) CONCENTRATIONS AND APOLIPOPROTEIN(A) PHENOTYPES IN HEMODIALYSIS, CHRONIC AMBULATORY PERITONEAL DIALYSIS AND POST-TRANSPLANT PATIENTS
E Kimak, J Solski |
Renal Failure | 2002 |
Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers
LH Puckey, BL Knight |
Biochemical Journal | 2002 |
Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism
C Gazzaruso, A Garzaniti, S Giordanetti, C Falcone, P Fratino |
Cardiovascular Diabetology | 2002 |
Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease
V Solfrizzi, F Panza, A D'Introno, AM Colacicco, C Capurso, AM Basile, A Capurso |
Journal of neurology, neurosurgery, and psychiatry | 2002 |
Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population
F Paultre, CH Tuck, B Boden-Albala, DE Kargman, E Todd, J Jones, MC Paik, RL Sacco, L Berglund |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Low birth weight is associated with elevated serum lipoprotein(a) in white and black American children ages 5–11 y
IS Okosun, GE Dever, ST Choi |
Public Health | 2002 |
A comprehensive linkage analysis for myocardial infarction and its related risk factors
U Broeckel, C Hengstenberg, B Mayer, S Holmer, LJ Martin, AG Comuzzie, J Blangero, P Nürnberg, A Reis, GA Riegger, HJ Jacob, H Schunkert |
Nature Genetics | 2002 |
Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases
M Akaike, H Azuma, A Kagawa, K Matsumoto, I Hayashi, K Tamura, T Nishiuchi, T Iuchi, N Takamori, K Aihara, T Yoshida, Y Kanagawa, T Matsumoto |
Clinical chemistry | 2002 |
Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease
S Martín, J Pedro-Botet, J Joven, JM Simó, MG Ladona, M Pavesi, J Rubiés-Prat |
Journal of Laboratory and Clinical Medicine | 2002 |
Low birth weight is associated with elevated serum lipoprotein(a) in white and black American children ages 5?11 y
I OKOSUN |
Public Health | 2002 |
Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease
U Lundstam, J Herlitz, T Karlsson, T Linden, O Wiklund |
Journal of Internal Medicine | 2002 |
Genetic and Environmental Influences on Lipids, Lipoproteins, and Apolipoproteins: Effects of Menopause
RP Middelberg, TD Spector, R Swaminathan, H Snieder |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Locus Controlling LDL Cholesterol Response to Dietary Cholesterol Is on Baboon Homologue of Human Chromosome 6
CM Kammerer, DL Rainwater, LA Cox, JL Schneider, MC Mahaney, J Rogers, JL VandeBerg |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism
U Nowak-Göttl, R Schobess, K Kurnik, D Schwabe, G Fleischhack, R Junker |
Blood | 2002 |
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians
J Rubin, F Paultre, CH Tuck, S Holleran, RG Reed, TA Pearson, CM Thomas, R Ramakrishnan, L Berglund |
Journal of lipid research | 2002 |
Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins
Kalpana Luthra, Balram Bharghav, Shivani Chabbra, Nibhriti Das, Anoop Misra, Dharam P Agarwal, Ravindra M Pandey, L M Srivastava |
Molecular and Cellular Biochemistry | 2002 |
Potentielle genetische Polymorphismen der venösen Thromboembolie. New Candidate Gene Polymorphisms in Venous Thrombosis
M Depka, S Ehrenforth |
LaboratoriumsMedizin | 2001 |
Journal of Cardiovascular Risk
S Kumbasar, I Dincer, F Ertas, S Gulec, C Erol, O Akyurek, M Kilickap, D Oral, E Sipahi, Y Laleli |
Journal of Cardiovascular Risk | 2001 |
Monogenic Dyslipidemias: Window on Determinants of Plasma Lipoprotein Metabolism
RA Hegele |
The American Journal of Human Genetics | 2001 |
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
C Lahoz, EJ Schaefer, LA Cupples, PW Wilson, D Levy, D Osgood, S Parpos, J Pedro-Botet, JA Daly, JM Ordovas |
Atherosclerosis | 2001 |
Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor
J Masuda, T Nabika, Y Notsu |
Current Opinion in Neurology | 2001 |
Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia
H Kim, SM Marcovina, KL Edwards, B McKnight, CM Bradley, MJ McNeely, BM Psaty, AG Motulsky, MA Austin |
Clinical Genetics | 2001 |
Genetic Evaluation of Lipoprotein(a) in Intracranial Aneurysm Disease
GA Roberts, BT Corcoran, LL Pfouts, JP Phillips, MA Farrell, DJ Bouchier-Hayes, PB Collins |
Neurosurgery | 2001 |
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects
C Gazzaruso, A Garzaniti, C Falcone, D Geroldi, G Finardi, P Fratino |
Diabetic Medicine | 2001 |
The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)n polymorphism with coronary heart disease
Á Kalina, A Császár, G Füst, B Nagy, C Szalai, I Karádi, J Duba, Z Prohászka, L Horváth, H Dieplinger |
Clinica Chimica Acta | 2001 |
The apolipoprotein(a) size, pentanucleotide repeat, C/T(+93) polymorphisms of apolipoprotein(a) gene, serum lipoprotein(a) concentrations and their relationship in a Korean population
JH Kim, KH Roh, SM Nam, HY Park, Y Jang, DK Kim, KS Song |
Clinica Chimica Acta | 2001 |
Atherosclerosis and Autoimmunity
EC Lau |
Atherosclerosis and Autoimmunity | 2001 |
Kringles of the plasminogen–prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site
M Dominguez, G Rojas, S Loyau, M Bazurco, L Sorell, E Anglés-Cano |
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology | 2001 |
Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men
M Seed, KL Ayres, SE Humphries, GJ Miller |
The American Journal of Medicine | 2001 |
Lipoproteína (a): fisiopatología y consideraciones clínicas y terapéuticas
L Enríquez, P Matas |
Medicina Clínica | 2001 |
Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects
L A Sechi, S De Marchi |
Journal of Investigative Medicine | 2001 |
Body fat, fat distribution and serum lipids, lipoproteins and apolipoproteins in African-American and Caucasian-American prepubertal children
SL Herd, BA Gower, N Dashti, MI Goran |
International Journal of Obesity | 2001 |
Functional Analysis of the Chimpanzee and Human apo(a) Promoter Sequences: IDENTIFICATION OF SEQUENCE VARIATIONS RESPONSIBLE FOR ELEVATED TRANSCRIPTIONAL ACTIVITY IN CHIMPANZEE
T Huby, C Dachet, RM Lawn, J Wickings, MJ Chapman, J Thillet |
The Journal of biological chemistry | 2001 |
Genetic linkage methods for quantitative traits
CI Amos, M Andrade |
Statistical Methods in Medical Research | 2001 |
Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia: Characterization of a New Plasma Fragment Pattern
S Gonbert, B Saint-Jore, P Giral, C Doucet, J Chapman, J Thillet |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
30th Hemophilia Symposium Hamburg 1999
I Scharrer, W Schramm |
2001 | |
Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene
J Rubin, TA Pearson, RG Reed, L Berglund |
Clinical chemistry | 2001 |
Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures
J Wang, J Boedeker, HH Hobbs, AL White |
Journal of lipid research | 2001 |
Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts
RC Hoogeveen, JK Gambhir, DS Gambhir, KT Kimball, K Ghazzaly, JW Gaubatz, M Vaduganathan, RS Rao, M Koschinsky, JD Morrisett |
Journal of lipid research | 2001 |
Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment
Z Tang, R P Tracy |
Journal of Thrombosis and Thrombolysis | 2001 |
Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels
M Paassilta, A Karjalainen, K Kervinen, MJ Savolainen, J Heikkinen, AC Bäckström, YA Kesäniemi |
Atherosclerosis | 2000 |
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow |
Annual Review of Genetics | 2000 |
LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level
O Rosby, K Berg |
Journal of Internal Medicine | 2000 |
Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients
LA Sechi, C Catena, D Casaccio, L Zingaro |
Journal of Hypertension | 2000 |
Premenopausal Black Women Are Uniquely at Risk for Coronary Heart Disease Compared to White Women
GT Gerhard, G Sexton, MR Malinow, RC Wander, SL Connor, AS Pappu, WE Connor |
Preventive Cardiology | 2000 |
Lipoprotein(a): a molecular vignette of an evolving risk factor
E Mohler |
ACC Current Journal Review | 2000 |
The effect of apolipoprotein(a)-, apolipoprotein E-, and apolipoprotein A4- polymorphisms on quantitative lipoprotein(a) concentrations
DI Boomsma, P Knijff, A Kaptein, C Labeur, NG Martin, LM Havekes, HM Princen |
Twin Research and Human Genetics | 2000 |
Cardiovascular risk markers in hypothalamic amenorrhoea
KK Miller, S Grinspoon, A Klibanski |
Clinical Endocrinology | 2000 |
Effects of normalization of GH hypersecretion on lipoprotein(a) and other lipoprotein serum levels in acromegaly
GF Castro, HF Escobar-Morreale, H Ortega, D Gómez-Coronado, JA Barro, C Varela, MA Lasunción |
Clinical Endocrinology | 2000 |
Prothrombotic Risk Factors in Children with Spontaneous Venous Thrombosis and Their Asymptomatic Parents
A Kosch, R Junker, K Kurnik, R Schobess, G Günther, HG Koch, U Nowak-Göttl |
Thrombosis Research | 2000 |
Relationship Between Lipoprotein(a) Phenotypes and Plaminogen Activator Inhibitor Type 1 in Diabetic Patients
C Hernández, P Chacón, L Garcı́a-Pascual, J Mesa, R Simó |
Thrombosis Research | 2000 |
Lipoprotein(a) in homozygous familial hypercholesterolemia
HG Kraft, A Lingenhel, FJ Raal, M Hohenegger, G Utermann |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Agregación entre hermanos de factores de riesgo cardiovascular: estudio de Cuenca
VM Vizcaíno, RF Gutiérrez, AL Muńoz, FS Aguilar, AM Sánchez, AC Herráiz |
Medicina Clínica | 2000 |
Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease
V Mooser, N Helbecque, J Miklossy, SM Marcovina, P Nicod, P Amouyel |
Annals of internal medicine | 2000 |
Lipoprotein(a), tobacco use, and risk of coronary heart disease
M Serrano, J Irala, M Palacios |
International Journal of Cardiology | 2000 |
Twenty-four hours of insulin infusion does not lower plasma lipoprotein(a) in healthy men
SC Riemens, RP Dullaart |
Scandinavian Journal of Clinical & Laboratory Investigation | 2000 |
Lipoprotein (a) and stroke
HJ Milionis |
Journal of clinical pathology | 2000 |
The Effect of Fasting in Ramadan on the Values and Interrelations between Biochemical, Coagulation and Hematological Factors
N Sarraf-Zadegan, M Atashi, GA Naderi, AM Baghai, S Asgary, MR Fatehifar, H Samarian, M Zarei |
Annals of Saudi medicine | 2000 |
Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns
V Mooser, MM Berger, L Tappy, C Cayeux, SM Marcovina, R Darioli, P Nicod, R Chioléro |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
An application of apo(a) isoforms for the clinical assessment of Lp(a)
S Takayama, Y Yasumuro, J h Kim, M Ishikawa, D Tsujino, S Matsuo, Y Harada, S Sugii |
Journal of Clinical Laboratory Analysis | 2000 |
Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]
J Fan, M Challah, H Shimoyamada, M Shiomi, S Marcovina, T Watanabe |
Journal of lipid research | 2000 |
Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure
F Kronenberg, E Kuen, E Ritz, R Junker, P König, G Kraatz, K Lhotta, JF Mann, GA Müller, U Neyer, W Riegel, P Riegler, V Schwenger, AV Eckardstein |
Journal of the American Society of Nephrology : JASN | 2000 |
A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly
BN Dardik, CD Schwartzkopf, DE Stevens, RE Chatelain |
Journal of lipid research | 2000 |
Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study
N F Chu, L Makowski, J B Chang, D J Wang, S H Liou, S M Shieh |
European Journal of Epidemiology | 2000 |
Lipoprotein (a) metabolism estimated by nonsteady-state kinetics
KG Parhofer, T Demant, MM Ritter, HC Geiss, M Donner, P Schwandt |
Lipids | 1999 |
Lipoprotein(a)
HH Hobbs, AL White |
Current Opinion in Lipidology | 1999 |
Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure
LA Sechi, L Zingaro, C Catena, A Perin, SD Marchi, E Bartoli |
Kidney International | 1999 |
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age
C Gazzaruso, A Garzaniti, P Buscaglia, G Bonetti, C Falcone, P Fratino, G Finardi, D Geroldi |
Journal of the American College of Cardiology | 1999 |
Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux
LB Nielsen |
Atherosclerosis | 1999 |
Lipoprotein metabolism during normal pregnancy
P Brizzi, G Tonolo, F Esposito, L Puddu, S Dessole, M Maioli, S Milia |
American Journal of Obstetrics and Gynecology | 1999 |
Associations Among Serum Lipoprotein(a) Levels, Apolipoprotein(a) Phenotypes, and Myocardial Infarction in Patients With Extremely Low and High Levels of Serum Lipoprotein(a)
K Saku, B Zhang, R Liu, K Shirai, K Arakawa |
Japanese Circulation Journal | 1999 |
Apolipoprotein(a) size polymorphism in young adults with ischemic stroke
J Peynet, JL Beaudeux, F Woimant, F Flourié, V Giraudeaux, E Vicaut, JM Launay |
Atherosclerosis | 1999 |
Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up
L Kerschdorfer, P König, U Neyer, C Bösmüller, K Lhotta, M Auinger, M Hohenegger, P Riegler, R Margreiter, G Utermann, H Dieplinger, F Kronenberg |
Atherosclerosis | 1999 |
Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians
K Valenti, E Aveynier, S Leauté, F Laporte, AJ Hadjian |
Atherosclerosis | 1999 |
Genetic architecture and evolution of the lipoprotein(a) trait
G Utermann |
Current Opinion in Lipidology | 1999 |
EFFECTS OF APOLIPOPROTEIN A GENE POLYMORPHISMS ON LIPOPROTEIN (a) CONCENTRATIONS IN JAPANESE
HY Park, T Nabika, Y Notsu, S Kobayashi, J Masuda |
Clinical and Experimental Pharmacology and Physiology | 1999 |
Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome
D Noto, CM Barbagallo, AL Cascio, AB Cefalu, G Cavera, R Caldarella, G Marino, S Travali, I Cutaia, S Maringhini, A Notarbartolo, M Averna |
Kidney International | 1999 |
Smoking and Lipid Cardiovascular Risk Factors in Vietnamese Refugees in Australia
M Bermingham, K Brock, D Tran, J Yau, H Tran-Dinh |
Preventive Medicine | 1999 |
Are risk factors for atherothrombotic disease associated with back pain sickness absence? The Whitehall II Study
H Hemingway, M Shipley, S Stansfeld, H Shannon, J Frank, E Brunner, M Marmot |
Journal of epidemiology and community health | 1999 |
Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: Relation to apolipoprotein(a) size polymorphism
M Arnadottir, AL Berg, F Kronenberg, A Lingenhel, T Hugosson, J Hegbrant, P Nilsson-Ehle |
Metabolism | 1999 |
Biochemical risk factors and patient's outcome: the case of lipoprotein(a)
G Lippi, G Guidi |
Clinica Chimica Acta | 1999 |
Relationship of lipoprotein(a) levels to physical activity and family history of coronary heart disease
S Martín, R Elosua, MI Covas, M Pavesi, J Vila, J Marrugat |
American journal of public health | 1999 |
Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: Relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels
JA Barth, RJ Deckelbaum, TJ Starc, S Shea, L Mosca, L Berglund |
Journal of Laboratory and Clinical Medicine | 1999 |
Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice
S Frank, A Hrzenjak, K Kostner, W Sattler, GM Kostner |
Biochimica et Biophysica Acta | 1999 |
6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a)
J Wang, AL White |
The Journal of biological chemistry | 1999 |
Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription
A Kagawa, H Azuma, M Akaike, Y Kanagawa, T Matsumoto |
The Journal of biological chemistry | 1999 |
Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure
HJ Milionis, MS Elisaf, A Tselepis, E Bairaktari, SA Karabina, KC Siamopoulos |
American Journal of Kidney Diseases | 1999 |
Lipoprotein (a): A controversial risk factor for atherosclerotic heart disease
AP Rocchini |
Journal of Laboratory and Clinical Medicine | 1999 |
Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study
L Brazier, L Tiret, G Luc, D Arveiler, J B Ruidavets, A Evans, J Chapman, F Cambien, J Thillet |
Atherosclerosis | 1999 |
Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort
A Gaw, G Docherty, E A Brown, I Ford |
Atherosclerosis | 1999 |
Lipoprotein(a), apolipoprotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardiovascular risk factors and nationality
K Aasvee, M Jauhiainen, E Kurvinen, R Jordania, J Sundvall, C Ehnholm |
Scandinavian Journal of Clinical & Laboratory Investigation | 1999 |
Estrogen Modulation of Apolipoprotein(a) Expression: IDENTIFICATION OF A REGULATORY ELEMENT
D Boffelli, DA Zajchowski, Z Yang, RM Lawn |
The Journal of biological chemistry | 1999 |
Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis
Y Asanuma, S Kawai, H Aoshima, J Kaburaki, Y Mizushima |
Arthritis & Rheumatism | 1999 |
Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein
K Nilausen, H Meinertz |
The American journal of clinical nutrition | 1999 |
Evidence That Multiple Genes Influence Baseline Concentrations and Diet Response of Lp(a) in Baboons
DL Rainwater, CM Kammerer, JL VandeBerg |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
D Périard, A Telenti, P Sudre, JJ Cheseaux, P Halfon, MJ Reymond, SM Marcovina, MP Glauser, P Nicod, R Darioli, V Mooser |
Circulation | 1999 |
Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood
U Nowak-Göttl, R Junker, M Hartmeier, HG Koch, N Münchow, G Assmann, A von Eckardstein |
Circulation | 1999 |
Evaluation of Genetic Risk Factors for Silent Brain Infarction
Y Notsu, T Nabika, HY Park, J Masuda, S Kobayashi |
Stroke; a journal of cerebral circulation | 1999 |
Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments
V Mooser, F Tinguely, P Fontana, V Lenain, M Vaglio, P Ruchat, LK von Segesser, SM Marcovina, M Markert, R Darioli, P Nicod |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Dose-Dependent Inverse Relationship Between Alcohol Consumption and Serum Lp(a) Levels in Black African Males
P Fontana, V Mooser, P Bovet, C Shamlaye, B Burnand, V Lenain, SM Marcovina, W Riesen, R Darioli |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Dissecting the Genetic Architecture of Lipids, Lipoproteins, and Apolipoproteins: Lessons From Twin Studies
H Snieder, LJ van Doornen, DI Boomsma |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Fish Intake, Independent of Apo(a) Size, Accounts for Lower Plasma Lipoprotein(a) Levels in Bantu Fishermen of Tanzania: The Lugalawa Study
SM Marcovina, H Kennedy, GB Bon, G Cazzolato, C Galli, E Casiglia, M Puato, P Pauletto |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Hämostaseologie
G Müller-Berghaus, B Pötzsch |
Hämostaseologie | 1999 |
Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway
AL White, B Guerra, J Wang, RE Lanford |
Journal of lipid research | 1999 |
No Relationship between Serum Lipoprotein(A) and Albumin Concentrations in Patients with Acute Phase Response
WK Min, S Chun, SH Hwang, H Park |
Annals of Clinical Biochemistry | 1999 |
Transgenic mice expressing a human apolipoprotein[a] allele
F Acquati, R Hammer, B Ercoli, V Mooser, R Tao, V Rönicke, A Michalich, G Chiesa, R Taramelli, HH Hobbs, HJ Müller |
Journal of lipid research | 1999 |
The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients: A Prospective Follow-Up
F Kronenberg, U Neyer, K Lhotta, EV Trenkwalder, M Auinger, A Pribasnig, T Meisl, P König, H Dieplinger |
Journal of the American Society of Nephrology : JASN | 1999 |
Glycated Hemoglobin Levels and Their Correlation With Atherosclerotic Risk Factors in a Japanese Population
K Kayaba, N Nago, T Miyamoto, M Mizooka, M Terada, K Kario, Y Nakamura, M lgarashi |
Japanese Circulation Journal | 1998 |
LP(a) phenotypes and levels in angiographically proven coronary heart disease patients and controls
K Luthra, S Vasisht, S Chhabra, KR Raju, DP Agarwal, SC Manchanda, LM Srivastava |
Indian Journal of Clinical Biochemistry | 1998 |
Job strain and biological coronary risk factors: A cross-sectional study of male and female workers in a japanese rural district
A Tsutsumi, K Tsutsumi, K Kayaba, T Theorell, N Nago, K Kario, M Igarashi |
International Journal of Behavioral Medicine | 1998 |
Pipoprotein Lp(a): Effects of allelic variation at theLPA locus
DL Rainwater, CM Kammerer |
The Journal of Experimental Zoology | 1998 |
Long-Term Variability of Serum Lipoprotein(a) Concentrations in Healthy Fertile Women
R Garnotel, F Monier, F Lefèvre, P Gillery |
Clinical Chemistry and Laboratory Medicine | 1998 |
Standardization and Clinical Management of Lipoprotein(a) Measurements
G Lippi, G Guidi |
Clinical Chemistry and Laboratory Medicine | 1998 |
Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study
DE Kargman, C Tuck, L Berglund, IF Lin, RS Mukherjee, EV Thompson, J Jones, B Boden-Albala, MC Paik, RL Sacco |
Atherosclerosis | 1998 |
Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response
G Lippi, V Braga, S Adami, G Guidi |
Clinica Chimica Acta | 1998 |
LIPOPROTEINS AND ATHEROGENESIS
JM Hoeg |
Endocrinology & Metabolism Clinics of North America | 1998 |
Oestrogen replacement therapy and coronary heart disease
MR Taskinen |
Annals of Medicine | 1998 |
UPDATE ON GENETIC RISK FACTORS FOR THROMBOSIS AND ATHEROSCLEROTIC VASCULAR DISEASE
EJ Neufeld |
Hematology/Oncology Clinics of North America | 1998 |
No Effect of Fibrates on Synthesis of Apolipoprotein(a) in Primary Cultures of Cynomolgus Monkey and Human Hepatocytes: Apolipoprotein A-I Synthesis Increased
DM Neele, A Kaptein, H Huisman, EC de Wit, HM Princen |
Biochemical and Biophysical Research Communications | 1998 |
Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS–agarose immunoblotting
S Martı́n, MG Ladona, J Pedro-Botet, MI Covas, J Rubiés-Prat |
Clinica Chimica Acta | 1998 |
Plasma Lipoprotein(a) Levels Are High in Patients with Central Retinal Artery Occlusion
M Murata, T Saito, S Takahashi, A Ichinose |
Thrombosis Research | 1998 |
Genetics of stroke—a review
D Rastenyt≐, J Tuomilehto, C Sarti |
Journal of the Neurological Sciences | 1998 |
Premenopausal black women have more risk factors for coronary heart disease than white women
GT Gerhard, G Sexton, MR Malinow, RC Wander, SL Connor, AS Pappu, WE Connor |
The American Journal of Cardiology | 1998 |
Atherothrombogenicity of lipoprotein(a): the debate
AM Scanu |
The American Journal of Cardiology | 1998 |
Lipoprotein(a) as a risk factor for coronary artery disease
SM Marcovina, ML Koschinsky |
The American Journal of Cardiology | 1998 |
Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity
C Gazzaruso, D Geroldi, A Garzaniti, C Falcone, P Fratino, G Finardi, P Buscaglia |
International Journal of Cardiology | 1998 |
Influence de l'exercice physique sur la concentration plasmatique de lipoprotéine(a) chez de jeunes athlètes
S Clavel, S Léauté, P Jouanel |
Science & Sports | 1998 |
Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect
A Gaw, E A Brown, I Ford |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Interactions among Lp(a) phenotypes, Lp(a) concentrations and lipoprotein response to fat-modified diets
YH Tsai, S Park, JT Snook |
The Journal of Nutritional Biochemistry | 1998 |
Apolipoprotein(a) Gene Enhancer Resides within a LINE Element
Z Yang, D Boffelli, N Boonmark, K Schwartz, R Lawn |
The Journal of biological chemistry | 1998 |
Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion
F Nassir, DK Bonen, NO Davidson |
The Journal of biological chemistry | 1998 |
The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States
Dahlen, Srinivasan, Srinivasan, Stenlund, Wattigney, Wall, Berenson |
Journal of Internal Medicine | 1998 |
Insulin and 2-Hour Glucose Levels Are Inversely Related to Lp(a) Concentrations Controlled for LPA Genotype
DL Rainwater, SM Haffner |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Alcohol Withdrawal–Induced Change in Lipoprotein(a): Association With the Growth Hormone/Insulin-like Growth Factor-I (IGF-I)/IGF-Binding Protein-1 (IGFBP-1) Axis
M Paassilta, K Kervinen, M Linnaluoto, YA Kesäniemi |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment
RL Wilensky |
1998 | |
Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro
DK Bonen, F Nassir, AM Hausman, NO Davidson |
Journal of lipid research | 1998 |
Molecular basis of an apolipoprotein[a] null allele: a splice sitemutation is associated with deletion of a single exon
LA Cox, C Jett, JE Hixson |
Journal of lipid research | 1998 |
Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region
K Suzuki, M Kuriyama, T Saito, A Ichinose |
Journal of Clinical Investigation | 1997 |
Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB
YY van der Hoek, A Lingenhel, HG Kraft, JC Defesche, JJ Kastelein, G Utermann |
Journal of Clinical Investigation | 1997 |
The Apo(a) Gene is the Major Determinant of Variation in Plasma Lp(a) Levels in African Americans
V Mooser, D Scheer, SM Marcovina, J Wang, R Guerra, J Cohen, HH Hobbs |
The American Journal of Human Genetics | 1997 |
Biogenesis of Lp(a) in transgenic mouse hepatocytes
AL White |
Clinical Genetics | 1997 |
Metabolism of Lp(a): assembly and excretion
GM Kostner, X Wo, S Frank, K Kostner, R Zimmermann, E Steyrer |
Clinical Genetics | 1997 |
Apolipoproteins and lipoprotein particles in moroccan patients with previous myocardial infarction
A Adlouni, ME Messal, N Ghalim, R SaÏle |
International Journal of Clinical & Laboratory Research | 1997 |
Lipoprotein (a) Concentrations in Patients with Various Dyslipidaemias
MS Elisaf, ET Bairaktari, CS Tzallas, KC Siamopoulos |
Annals of Medicine | 1997 |
High-degree sequence conservation in LPA kringle IV-type 2 exons and introns
O Rösby, P Aleström, K Berg |
Clinical Genetics | 1997 |
Lipoprotein(a): structural implications for pathophysiology
ML Koschinsky, SM Marcovina |
International Journal of Clinical & Laboratory Research | 1997 |
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension
C Gazzaruso, P Buscaglia, A Garzaniti, C Falcone, S Mariotti, S Savino, G Bonetti, G Finardi, D Geroldi |
Journal of Hypertension | 1997 |
Serum distribution of lipoprotein(a) in African Americans and Nigerians: Potential evidence for a genotype-environmental effect
CN Rotimi, RS Cooper, SM Marcovina, D McGee, E Owoaje, M Ladipo |
Genetic Epidemiology | 1997 |
Liprotein(a) Phenotypes in Japanese Children: A Cohort Study
O Arisaka, S Fujiwara, N Miyake, H Mokuno, K Yabuta |
Journal of Pediatric Gastroenterology & Nutrition | 1997 |
Opposing Effects of Growth Hormone and Insulin-like Growth Factor I on Serum Lipoprotein(a)
Z Laron, B Klinger, A Silbergeld, XL Wang |
Journal of Pediatric Endocrinology and Metabolism | 1997 |
Is it time to measure Lp(a) as part of coronary heart disease risk assessment?
R Hegele |
Clinical Biochemistry | 1997 |
Tracking of Serum Lipoprotein (a) Concentration and Its Contribution to Serum Cholesterol Values in Children from 7 to 36 Months of Age in the STRIP Baby Study
T Routi, T Rönnemaa, JS Viikari, A Leino, LA Välimaki, OG Simell |
Annals of Medicine | 1997 |
High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay
V Mooser, SM Marcovina, J Wang, HH Hobbs |
Clinical Genetics | 1997 |
LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients
F Kronenberg, E Trenkwalder, W Sturm, H Kathrein, P König, U Neyer, E Gröchenig, G Utermann, H Dieplinger |
Clinical Genetics | 1997 |
Lipoprotein (a) and the kidney
BG MURPHY |
Nephrology | 1997 |
Reporter gene analysis of four DNasel hypersensitive sites in the plasminogen/apolipoprotein(a) intergenic region
F Acquati, V Rönicke, R Taramelli, HJ Müller |
Clinical Genetics | 1997 |
The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins
H Snieder, LJ van Doornen, DI Boomsma |
The American Journal of Human Genetics | 1997 |
LIPOPROTEIN(a) CONCENTRATION AND MOLECULAR WEIGHT OF APOLIPOPROTEIN(a) IN PATIENTS WITH CEREBROVASCULAR DISEASE AND DIABETES MELLITUS
T Saito, R Ookubo, M Kuriyama, R Sano, A Ichinose |
Thrombosis Research | 1997 |
Lipoprotein (a) distribution in a Nigerian population
RW Evans, CH Bunker, FA Ukoli, LH Kuller |
Ethnicity and Health | 1997 |
Genomic structure and organisation of kringles type 3 to 10 of the apolipoprotein(a) gene in 6q26–27
A Mihalich, P Magnaghi, L Sessa, M Trubia, F Acquati, R Taramelli |
Gene | 1997 |
Monthly intra-individual variation in lipoprotein(a) in 22 normal subjects over 12 months
DJ Nazir, MJ McQueen |
Clinical Biochemistry | 1997 |
Small genetic effects in complex diseases: A review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis
RA Hegele |
Clinical Biochemistry | 1997 |
Comparative Analysis of Apo(A) Gene Alleles: Distribution of Pentanucleotide Repeats in Position −1373 and C/T Transition in Position +93 among Patients with Myocardial Infarction and a Control Group in St. Petersburg, Russia
MV Volkova, VI Vasina, EV Fomicheva, EI Schwartz |
Biochemical and Molecular Medicine | 1997 |
Pentaerythritol tetranicotinate (niceritrol) decreases plasma lipoprotein(a) levels
K Tanaka, K Hayashi, T Shingu, Y Kuga, Y Okura, Y Yasunobu, H Ohtani, S Nomura, H Kurushima, M Saeki, M Kambe, G Kajiyama |
Metabolism | 1997 |
Serum LP(a) levels in African Aboriginal Pygmies and Bantus, Compared with Caucasian and Asian Population samples
C Cobbaert, P Mulder, J Lindemans, H Kesteloot |
Journal of Clinical Epidemiology | 1997 |
Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease: Rapid Communication
E Trenkwalder, A Gruber, P König, H Dieplinger, F Kronenberg |
Kidney International | 1997 |
Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a)
DL Rainwater, CM Kammerer, JL VandeBerg, JE Hixson |
Atherosclerosis | 1997 |
Influence of Allelic Variation on Apolipoprotein(a) Folding in the Endoplasmic Reticulum
AL White, B Guerra, RE Lanford |
The Journal of biological chemistry | 1997 |
Urinary apo(a) discriminates coronary artery disease patients from controls
KM Kostner, K Huber, T Stefenelli, H Rinner, G Maurer |
Atherosclerosis | 1997 |
Characterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene
DP Wade, LH Puckey, BL Knight, F Acquati, A Mihalich, R Taramelli |
The Journal of biological chemistry | 1997 |
Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a)
MM Ritter, J Gewitsch, WO Richter, HC Geiss, MW Wildner, P Schwandt |
Atherosclerosis | 1997 |
Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells: EVIDENCE FOR INTRACELLULAR ASSEMBLY OF LIPOPROTEIN(a)
DK Bonen, AM Hausman, C Hadjiagapiou, SF Skarosi, NO Davidson |
The Journal of biological chemistry | 1997 |
Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
E Anglés-Cano |
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] | 1997 |
A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants
SH Wild, SP Fortmann, SM Marcovina |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Effects of Estrus Cycle, Ovariectomy, and Treatment with Estrogen, Tamoxifen, and Progesterone on Apolipoprotein(a) Gene Expression in Transgenic Mice
BR Zysow, K Kauser, RM Lawn, GM Rubanyi |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women
CH Tuck, S Holleran, L Berglund |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration
RA Hegele, WC Breckenridge, JH Brunt, PW Connelly |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
PN Hopkins, LL Wu, SC Hunt, BC James, GM Vincent, RR Williams |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Identification of Apo(a) Phenotypes in a Korean Population Using a Standardized Nomenclature System Based on the Number of Kringle IV Repeats
WK Min, JO Lee, CH Kim, J Song, JQ Kim |
Annals of Clinical Biochemistry | 1997 |
Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders
YY van der Hoek, RJ Wanders, AE van den Ende, HG Kraft, BR Gabel, JJ Kastelein, ML Koschinsky |
Journal of lipid research | 1997 |
Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22
DA Wu, X Bu, CH Warden, DD Shen, CY Jeng, WH Sheu, MM Fuh, T Katsuya, VJ Dzau, GM Reaven, AJ Lusis, JI Rotter, YD Chen |
Journal of Clinical Investigation | 1996 |
Lp(a) concentrations are related to plasma lipid concentrations
DL Rainwater |
Atherosclerosis | 1996 |
Lipoprotein(a) in renal disease
F Kronenberg, G Utermann, H Dieplinger |
American Journal of Kidney Diseases | 1996 |
Lipoprotein(a) is increased in triglyceride-rich lipoproteins in men with coronary heart disease, but does not change acutely following oral fat ingestion
F Hoppichler, HG Kraft, C Sandholzer, M Lechleitner, JR Patsch, G Utermann |
Atherosclerosis | 1996 |
The effect of labor force participation on coronary heart disease risk factors among middle-aged women: A cross-sectional study in a Japanese rural district
K Tsutsumi, A Tsutsumi, K Orth-Gomér |
International Journal of Behavioral Medicine | 1996 |
Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease
H Amemiya, T Arinami, S Kikuchi, K Yamakawa-Kobayashi, L Li, H Fujiwara, M Hiroe, F Marumo, H Hamaguchi |
Atherosclerosis | 1996 |
Interrelationship of triglyceride-rich lipoproteins, serum lipoprotein(a) concentration and apolipoprotein(a) size
M SentÍ, J Pedro-Botet, J Rubiés-Prat, J Marrugat |
Scandinavian Journal of Clinical & Laboratory Investigation | 1996 |
The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes
HG Kraft, A Lingenhel, G Bader, GM Kostner, G Utermann |
Atherosclerosis | 1996 |
N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels
O Wiklund, G Fager, A Andersson, U Lundstam, P Masson, B Hultberg |
Atherosclerosis | 1996 |
Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level
SM Marcovina, G Lippi, CJ Bagatell, WJ Bremner |
Atherosclerosis | 1996 |
Lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in normoglycaemic relatives of Type 2 diabetic patients
MW Stewart, JM Webster, D Humphriss, T Berrish, M Walker, MF Laker |
Atherosclerosis | 1996 |
Treatment with growth hormone increases lipoprotein(a) serum levels in children with chronic renal insufficiency
U Querfeld, D Haffner, E Wühl, AM Wingen, K Wolter, B Friedrich, DV Michalk, O Mehls |
European Journal of Pediatrics | 1996 |
Lipoprotein(a) is not elevated in non-diabetic microalbuminuric subjects
JS Yudkin, SM Marcovina, WJ Foyle, M Fernandez |
International Journal of Clinical & Laboratory Research | 1996 |
Correlation of toddlers' serum lipoprotein(a) concentration with parental values and grandparents' coronary heart disease: the STRIP baby study
T Routi, T Rönnemaa, E Jokinen, J Viikari, H Niinikoski, A Leino, O Simell |
Acta Paediatrica | 1996 |
Molecular genetics as the route to understanding, prevention, and treatment
A Hamsten |
The Lancet | 1996 |
Serum lipoprotein(a) [Lp(a)] in alcoholic men: Effect of withdrawal
J Delarue, M Husson, F Schellenberg, J Tichet, S Vol, C Couet, F Lamisse |
Alcohol | 1996 |
Racial Variation of Cord Plasma Lipoprotein(a) Levels in Relation to Coronary Risk Level: A Study in Three Ethnic Groups in Singapore
PS Low, CK Heng, N Saha, JS Tay |
Pediatric Research | 1996 |
Urinary excretion of testosterone and estradiol in chinese men and relationships with serum lipoprotein concentrations
LS Ooi, NS Panesar, JR Masarei |
Metabolism | 1996 |
Lipoprotein(a) in Health and Disease
F Kronenberg, A Steinmetz, GM Kostner, H Dieplinger |
Critical Reviews in Clinical Laboratory Sciences | 1996 |
Mixture distributions in human genetics research
NJ Schork, DB Allison, B Thiel |
Statistical Methods in Medical Research | 1996 |
The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells
C Brunner, EM Lobentanz, A Pethö-Schramm, A Ernst, C Kang, H Dieplinger, HJ Müller, G Utermann |
The Journal of biological chemistry | 1996 |
Effect of a single session of exercise on lipoprotein(a):
JL Durstine, MA Ferguson, LM Szymanski, PG DAVIS, NL Alderson, SG Trost, RR Pate |
Medicine and Science in Sports and Exercise | 1996 |
Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect
R Carmena, S Lussier-Cacan, M Roy, A Minnich, A Lingenhel, F Kronenberg, J Davignon |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Plasma Lipoprotein(a) Levels in Subjects Attending a Metabolic Ward: Discrimination Between Individuals With and Without a History of Ischemic Stroke
M Margaglione, G DiMinno, E Grandone, E Celentano, G Vecchione, G Cappucci, M Grilli, FP Mancini, A Postiglione, S Panico, M Mancini |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Lipoprotein(a) in Patients With Acute Cerebral Ischemia
F van Kooten, J van Krimpen, DW Dippel, N Hoogerbrugge, PJ Koudstaal |
Stroke; a journal of cerebral circulation | 1996 |
Hormone Replacement Therapy Lowers Plasma Lp(a) Concentrations: Comparison of Cyclic Transdermal and Continuous Estrogen-Progestin Regimens
MR Taskinen, J Puolakka, T Pyörälä, H Luotola, M Björn, J Kääriäinen, S Lahdenperä, C Ehnholm |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease
HG Kraft, A Lingenhel, S Köchl, F Hoppichler, F Kronenberg, A Abe, V Mühlberger, D Schönitzer, G Utermann |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women: The Framingham Offspring Study
S Lamon-Fava, PW Wilson, EJ Schaefer |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson |
1996 | |
Triggering of Acute Coronary Syndromes
SN Willich, JE Muller |
1996 | |
Neomycin inhibits secretion of apolipoprotein[a] by increasing retention on the hepatocyte cell surface
RE Lanford, L Estlack, AL White |
Journal of lipid research | 1996 |
Identification of promoter sequences in the 5' untranslated region of the baboon apolipoprotein[a] gene
JE Hixson, C Jett, S Birnbaum |
Journal of lipid research | 1996 |
Treatment with growth hormone increases lipoprotein(a) serum levels in children with chronic renal insufficiency
U Querfeld, D Haffner, E Wühl, , K Wolter, B Friedrich, DV Michalk, O Mehls |
European Journal of Pediatrics | 1996 |
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans
DJ Rader, WA Mann, W Cain, HG Kraft, D Usher, LA Zech, JM Hoeg, J Davignon, P Lupien, M Grossman |
Journal of Clinical Investigation | 1995 |
A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians
M Trommsdorff, S Köchl, A Lingenhel, F Kronenberg, R Delport, H Vermaak, L Lemming, IC Klausen, O Faergeman, G Utermann |
Journal of Clinical Investigation | 1995 |
Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)
MJ Callow, J Verstuyft, R Tangirala, W Palinski, EM Rubin |
Journal of Clinical Investigation | 1995 |
Lipoprotein (a) in patients with hyperlipidaemia
W Bartens, DJ Rader, G Talley, HB Brewer |
European Journal of Clinical Investigation | 1995 |
Kringle-dependent structural and functional polymorphism of apolipoprotein (a)
A Scanu |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1995 |
Genetic basis for multimodal relationship between apolipoprotein (a) size and lipoprotein (a) concentration in Mexican-Americans
DL Rainwater |
Atherosclerosis | 1995 |
Further characterization of the plasma lipoprotein(a) distribution
W Craig, S Poulin, A Bostom, C Eaton, J Laurino, T Ledue, R Ritchie |
Journal of Clinical Laboratory Analysis | 1995 |
Potential environmental effects on adult lipoprotein(a) levels: results from Swedish twins
Y Hong, GH Dahlén, N Pedersen, DA Heller, GE McClearn, U Faire |
Atherosclerosis | 1995 |
The apolipoprotein(a) gene is regulated by sex hormones and acute–phase inducers in YAC transgenic mice
KA Frazer, G Narla, JL Zhang, EM Rubin |
Nature Genetics | 1995 |
Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men
J Oscarsson, U Lundstam, BJ Gustafsson, P Wilton, S Edén, O Wlklund |
Clinical Endocrinology | 1995 |
Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American Black women
MI Kamboh, RW Evans, CE Aston |
Atherosclerosis | 1995 |
High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism
A Császár, I Karádi, E Juhász, L Romics |
European Journal of Clinical Investigation | 1995 |
Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease
HK Jensen, PS Hansen, LG Jensen, MJ Kristensen, IC Klausen, M Kjeldsen, L Lemming, L Bolund, N Gregersen, O Faergeman |
Clinical Genetics | 1995 |
Elevated Levels of Lipoprotein (a) in Association with Cerebrovascular Saccular Aneurysmal Disease
C Bolger, J Phillips, S Gilligan, T Zourob, M Farrell, D Croake, P Collins, D Bouchier-Hayes |
Neurosurgery | 1995 |
Malignant coronary artery disease in young asian indians: Thoughts on pathogenesis, prevention, and therapy
EA Enas, J Mehta |
Clinical Cardiology | 1995 |
Lipoprotein (a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica
S Wållberg-Jonsson, A Uddhammar, G Dahlén, S Rantapää-Dahlqvist |
Scandinavian Journal of Clinical & Laboratory Investigation | 1995 |
Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus
CA DeMeester, X Bu, RJ Gray, AJ Lusis, JI Rotter |
The American Journal of Human Genetics | 1995 |
Method-dependent increase in lipoprotein(a) in insulin-dependent diabetes mellitus during pregnancy
HL Pekelharing, NL Aalders, GH Visser, JJ van Doormaal, BN Bouma, HA Kleinveld, HJ van Rijn |
Metabolism | 1995 |
Lipoprotein (a)
PN Durrington |
Baillière's Clinical Endocrinology and Metabolism | 1995 |
Whether, to what degree, and why lipoprotein(a) levels change over time
CJ Glueck, T Tracy, L Sieve-Smith, P Wang |
Clinica Chimica Acta | 1995 |
An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk
PM Ridker |
Trends in Cardiovascular Medicine | 1995 |
Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women
G Tonolo, M Ciccarese, P Brizzi, S Milia, S Dessole, L Puddu, G Secchi, M Maioli |
American journal of physiology. Endocrinology and metabolism | 1995 |
Elevated Levels of Lipoprotein (a) in Association with Cerebrovascular Saccular Aneurysmal Disease:
C Bolger, J Phillips, S Gilligan, T Zourob, M Farrell, D Croake, P Collins, D Bouchier-Hayes |
Neurosurgery | 1995 |
C/T Polymorphism in the 5′ Untranslated Region of the Apolipoprotein(a) Gene Introduces an Upstream ATG and Reduces In Vitro Translation
BR Zysow, GE Lindahl, DP Wade, BL Knight, RM Lawn |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Familial Hypobetalipoproteinemia Is Not Associated With Low Levels of Lipoprotein(a)
M Averna, SM Marcovina, D Noto, TG Cole, ES Krul, G Schonfeld |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Lipid and Lipoprotein Factors Associated With Variation in Lp(a) Density
DL Rainwater, MJ Ludwig, SM Haffner, JL VandeBerg |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Genetic Basis of Lipoprotein Disorders
M Dammerman, JL Breslow |
Circulation | 1995 |
No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans
DJ Moliterno, EV Jokinen, AR Miserez, RA Lange, JE Willard, E Boerwinkle, LD Hillis, HH Hobbs |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Hormonal Regulation of Serum Lipoprotein(a) Levels: Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor–I
H Olivecrona, AG Johansson, E Lindh, S Ljunghall, L Berglund, B Angelin |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Effects of Alcohol Consumption on Lipoproteins of Premenopausal Women: A Controlled Diet Study
BA Clevidence, ME Reichman, JT Judd, RA Muesing, A Schatzkin, EJ Schaefer, Z Li, J Jenner, CC Brown, M Sunkin, WS Campbell, PR Taylor |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Lipoprotein(a) and Asymptomatic Carotid Artery Disease: Evidence of a Prominent Role in the Evolution of Advanced Carotid Plaques: The Bruneck Study
J Willeit, S Kiechl, P Santer, F Oberhollenzer, G Egger, E Jarosch, A Mair |
Stroke; a journal of cerebral circulation | 1995 |
Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients
K Hirata, K Saku, S Jimi, S Kikuchi, H Hamaguchi, K Arakawa |
Diabetologia | 1995 |
Nutrition and Biotechnology in Heart Disease and Cancer
JB Longenecker, D Kritchevsky, MK Drezner |
1995 | |
Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein and liver apolipoprotein[a] mRNA levels
R Ramharack, MA Spahr, GW Hicks, KA Kieft, DW Brammer, LL Minton, RS Newton |
Journal of lipid research | 1995 |
Ten allelic apolipoprotein[a] 5' flanking fragments exhibit comparable promoter activities in HepG2 cells
S Bopp, S Köchl, F Acquati, P Magnaghi, A Pethö-Schramm, HG Kraft, G Utermann, HJ Müller, R Taramelli |
Journal of lipid research | 1995 |
Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein (a) size polymorphism
HG Kraft, C Haibach, A Lingenhel, C Brunner, M Trommsdorff, F Kronenberg, HJ Mller, G Utermann |
Human Genetics | 1995 |
Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles
YF Perombelon, AK Soutar, BL Knight |
Journal of Clinical Investigation | 1994 |
Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus
A Gaw, E Boerwinkle, JC Cohen, HH Hobbs |
Journal of Clinical Investigation | 1994 |
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate
DJ Rader, W Cain, K Ikewaki, G Talley, LA Zech, D Usher, HB Brewer |
Journal of Clinical Investigation | 1994 |
The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma
E Steyrer, S Durovic, S Frank, W Giessauf, A Burger, H Dieplinger, R Zechner, GM Kostner |
Journal of Clinical Investigation | 1994 |
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
JC Cohen, Z Wang, SM Grundy, MR Stoesz, R Guerra |
Journal of Clinical Investigation | 1994 |
Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis
WL Gregory, FL Game, M Farrer, JR Idle, MF Laker, OF James |
Atherosclerosis | 1994 |
Studies on the structure and function of the apolipoprotein(a) gene
CD Byrne, RM Lawn |
Clinical Genetics | 1994 |
Lipoprotein(a) in Type 1 Diabetic Patients with Renal Disease
PH Groop, GC Viberti, TG Elliott, R Friedman, A Mackie, C Ehnholm, M Jauhiainen, MR Taskinen |
Diabetic Medicine | 1994 |
Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia
G Feussner, V Feussner, R Ziegler |
Journal of Internal Medicine | 1994 |
Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia
W Bartens, DJ Rader, G Talley, HB Brewer |
Atherosclerosis | 1994 |
Lp(a) lipoprotein in cardiovascular disease
GH Dahlén |
Atherosclerosis | 1994 |
Apo(a) Expression in Transgenic Micea
HH Hobbs, G Chiesa, A Gaw, R Lawn, SD Maika, M Koschinsky, R Hammer |
Annals of the New York Academy of Sciences | 1994 |
Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia
MM Ritter, HC Geiss, WO Richter, P Schwandt |
Metabolism | 1994 |
Serum lipoprotein(a) level is increased in patients with systemic lupus erythematosus irrespective of positivity of antiphospholipid antibodies
J Matsuda, M Gotoh, K Gohchi, N Saitoh, M Tsukamoto |
Thrombosis Research | 1994 |
The relationship between infant and parent Lp(a) levels
DE Wilcken, XL Wang, NP Dudman |
Chemistry and Physics of Lipids | 1994 |
The apolipoprotein(a) gene: characterization of 5′ flanking regions and expression in transgenic mice
RM Lawn |
Chemistry and Physics of Lipids | 1994 |
Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus
SM Haffner, M Frangos, J Williamson, J Santiago, R Valdez, G Aldrete, L Mykkänen, KK Gruber, DL Rainwater |
Chemistry and Physics of Lipids | 1994 |
Lipoprotein(a) and coronary heart disease
CR Rodriguez, LJ Seman, JM Ordovas, J Jenner, MS Genest, PW Wilson, EJ Schaefer |
Chemistry and Physics of Lipids | 1994 |
Hypervariable polymorphism of APO(a) in blacks and whites as reflected by phenotyping
MI Kamboh, CM Svitko, ER Williams, RE Ferrell, WS Pollitzer |
Chemistry and Physics of Lipids | 1994 |
Hormonal agents used in lowering lipoprotein(a)
MR Soma, M Meschia, F Bruschi, JD Morrisett, R Paoletti, R Fumagalli, PG Crosignani |
Chemistry and Physics of Lipids | 1994 |
Intracellular processing of apo(a) in primary baboon hepatocytes
AL White, DL Rainwater, JE Hixson, LE Estlack, RE Lanford |
Chemistry and Physics of Lipids | 1994 |
Structure and Possible biological roles of Lp(a)
I Karmansky, N Gruener |
Clinical Biochemistry | 1994 |
High allele frequency of apolipoprotein(a) phenotype LpS4 is associated with low serum Lp(a) concentrations in Koreans
JQ Kim, JH Song |
Clinical Biochemistry | 1994 |
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
P Cremer, D Nagel, B Labrot, H Mann, R Muche, H Elster, D Seidel |
European Journal of Clinical Investigation | 1994 |
Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease
MA Austin, JE Hokanson |
Medical Clinics of North America | 1994 |
Lipoprotein disorders in diabetes mellitus
WV Brown |
Medical Clinics of North America | 1994 |
High-Level Expression of Various Apolipoprotein (a) Isoforms by "Transferrinfection": The Role of Kringle IV Sequences in the Extracellular Association with Low-Density Lipoprotein
S Frank, K Krasznai, S Durovic, EM Lobentanz, H Dieplinger, E Wagner, K Zatloukal, M Cotten, G Utermann |
Biochemistry | 1994 |
Structural Domains of Apolipoprotein(a) and Its Interaction with Apolipoprotein B-100 in the Lipoprotein(a) Particle
T Huby, C Doucet, H Dieplinger, J Chapman, J Thillet |
Biochemistry | 1994 |
Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients
N Azrolan, CD Brown, L Thomas, T Hayek, ZH Zhao, KG Roberts, C Scheiner, EA Friedman |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease
F Kronenberg, H Kathrein, P König, U Neyer, W Sturm, K Lhotta, E Gröchenig, G Utermann, H Dieplinger |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation
F Kronenberg, P König, K Lhotta, D Ofner, C Sandholzer, R Margreiter, E Dosch, G Utermann, H Dieplinger |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men
SM Haffner, L Mykkanen, KK Gruber, DL Rainwater, M Laakso |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease
S Islam, B Gutin, C Smith, F Treiber, MI Kamboh |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms
M Farrer, FL Game, CJ Albers, HA Neil, PH Winocour, MF Laker, PC Adams, KG Alberti |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women
CJ Kim, HC Jang, DH Cho, YK Min |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
Principles and Treatment of Lipoprotein Disorders
G Schettler, AJ Habenicht |
1994 | |
Women’s Health in Menopause
PG Crosignani, R Paoletti, PM Sarrel, NK Wenger, M Meschia, M Soma |
1994 | |
Molecular basis for “null” lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon
AL White, JE Hixson, DL Rainwater, RE Lanford |
The Journal of biological chemistry | 1994 |
Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes
AL White, RE Lanford |
The Journal of biological chemistry | 1994 |
Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500–>Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins
S Durovic, W Mrz, S Frank, H Scharnagl, MW Baumstark, R Zechner, GM Kostner |
The Journal of biological chemistry | 1994 |
Lipoprotein[a] in the chimpanezee: relationship of apo[a] phenotype to elevated plasma Lp[a] levels
C Doucet, T Huby, J Chapman, J Thillet |
Journal of lipid research | 1994 |
Apolipoprotein(a) gene transcription is regulated by liver-enriched trans-acting factor hepatocyte nuclear factor 1 alpha
DP Wade, GE Lindahl, RM Lawn |
The Journal of biological chemistry | 1994 |
Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia implication for lipoprotein(a) metabolism
G Lindahl, F Mailly, S Humphries, M Seed |
The Clinical Investigator | 1994 |
Lipoprotein(a) : new insights into an atherogenic lipoprotein
W Bartens, C Wanner |
The Clinical Investigator | 1994 |
Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels
JC Cohen, G Chiesa, HH Hobbs |
Journal of Clinical Investigation | 1993 |
Lipoprotein(a) in nephrotic syndrome
P Stenvinkel, L Berglund, O Heimbürger, E Pettersson, A Alvestrand |
Kidney International | 1993 |
Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus
K Hirata, S Kikuchi, K Saku, S Jimi, B Zhang, S Naito, H Hamaguchi, K Arakawa |
Kidney International | 1993 |
Apolipoprotein (a): A comparison of isoforms identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis or by sodium dodecyl sulfate-agarose gel electrophoresis
WY Craig, SE Poulin, TB Ledue, MI Kamboh |
Electrophoresis | 1993 |
Genetics of atherosclerosis: Some strategies for studies of apolipoprotein E
PP Moll |
American Journal of Human Biology | 1993 |
5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family
DP Wade, JG Clarke, GE Lindahl, AC Liu, BR Zysow, K Meer, K Schwartz, RM Lawn |
Proceedings of the National Academy of Sciences | 1993 |
Plasma predictors of ischemic complications of atherosclerosis: open issues
M Margaglione, E Grandone, GD Minno |
Biomedicine & Pharmacotherapy | 1993 |
Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents
DE Wilcken, XL Wang, J Greenwood, J Lynch |
The Journal of Pediatrics | 1993 |
Lipoprotein(a) in Patients Treated by Continuous Ambulatory Peritoneal Dialysis
J Thillet, C Faucher, B Issad, M Allouache, J Chapman, C Jacobs |
American Journal of Kidney Diseases | 1993 |
Acute myocardial infarction in a young man
RL Duerr, RS Ross |
Trends in Cardiovascular Medicine | 1993 |
The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study
SA Brown, JD Morrisett, E Boerwinkle, R Hutchinson, W Patsch |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients
A von Eckardstein, J Heinrich, H Funke, H Schulte, R Schönfeld, E Köhler, A Steinmetz, G Assmann |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study
JL Jenner, JM Ordovas, S Lamon-Fava, MM Schaefer, PW Wilson, WP Castelli, EJ Schaefer |
Circulation | 1993 |
Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study
SM Marcovina, JJ Albers, DR Jacobs, LL Perkins, CE Lewis, BV Howard, P Savage |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
Frequent occurrence of familial aggregations of high lipoprotein(a) levels associated with small apolipoprotein(a) isoforms
H Yanagi, A Nakagawa, S Kikuchi, T Tanaka, S Tsuchiya, H Hamaguchi |
Human Genetics | 1993 |
High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations
S Kikuchi, A Nakagawa, K Kobayashi, L Li, H Yanagi, T Arinami, Y Kozu, R Miyazaki, S Tsuchiya, H Hamaguchi |
Human Genetics | 1993 |
Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease
M Farrer, FL Game, CJ Albers, HA Neil, PH Winocour, MF Laker, PC Adams, KG Alberti |
BMJ : British Medical Journal | 1993 |
Serum LP(A) levels in randomized healthy men from different European countries
M Cigolini, JC Seidell, MG Zenti, G Bonadonna, L Zambelli, JP Deslypere, F Contaldo, A Cruz, J Charzewska, G Targher, M Muggeo |
European Journal of Epidemiology | 1993 |
Arterial hardening in mice
J Scott |
Nature | 1992 |